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DISSERTATION ABSTRACT 
 
Jacqlyn Hyler King 
 
Doctor of Philosophy 
 
Department of Human Physiology 
 
December 2017 
 
Title: Sensorimotor Abnormalities in Chronic Subacromial Pain: The Influence of Sex, 
Contribution of Pain, and Utility of Using the Contralateral Limb as a Control 
 
 
Patients with subacromial pain syndrome (SPS) display a number of sensorimotor 
deficits including alterations in pain processing, poor proprioception, and weakness at the 
symptomatic limb. The primary purpose of this dissertation was to explore whether the 
aforementioned deficits: (1) can be quantified by using the non-involved limb as a 
measure of control, (2) are purely localized to the symptomatic limb or represent a more 
generalized deficit, (3) are influenced by the presence of subacromial pain, and (4) 
present similarly in male and female patients. Here, we utilized modern clinical 
techniques in both a patient cohort with SPS and uninjured control cohort to address these 
aims. The results of this dissertation are applicable towards treatment of SPS as well as 
scientific understanding of sex on sensorimotor behavior. 
This dissertation includes unpublished coauthored material. 
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CHAPTER I 
 
INTRODUCTION 
 
Significance 
Each year chronic pain affects more Americans than heart disease, diabetes, and 
cancer combined, making it the most cited reason for healthcare consumption (U.S. 
Department of Health and Human Services, 2013). Within the middle aged and working 
populations, shoulder pain is one of the leading sources of chronic pain, long-term 
disability, and psychological distress (Meislin et al., 2005). More specifically, shoulder 
pain ranks second or third behind back pain as the most frequent musculoskeletal 
complaint within the general population (Picavet and Schouten, 2003; Urwin et al., 
1998). Between 7% and 26% of adults experience shoulder pain at any given time 
(Luime et al., 2004), producing enormous socioeconomic impacts. In 2000, the direct 
cost for treating shoulder pain in the United States totaled approximately $7 billion 
(Meislin et al., 2005), while the indirect costs associated with lost work or productivity 
are estimated to have exceeded this figure (Dorrestijn et al., 2011). 
Shoulder pain can be particularly debilitating, with roughly 30% of persons with 
shoulder pain reporting limitations in activities of daily living (Picavet and Schouten, 
2003). Limitations in occupational or self-care tasks arise from pain as well as difficulties 
producing adequate strength, performing repetitive tasks, and positioning the arm above 
the shoulder, near the back of the head or near the gluteal region (Hall et al., 2011; van 
der Windt et al., 1995). Aside from the physical burdens, patients with shoulder pain also 
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experience substantial psychological burdens including sleep disturbances, depression, 
anxiety, and lower quality of life (Bodin et al., 2014; Cho et al., 2013). 
Rotator cuff tears, subacromial pain syndrome (SPS), glenohumeral osteoarthritis, 
glenohumeral instability, and adhesive capsulitis are all common causes of shoulder pain. 
Of these conditions, SPS is the predominant cause of shoulder pain, accounting for 
approximately half of all shoulder complaints (Dorrestijn et al., 2011; Meislin et al., 
2005). SPS is known by many other names, including rotator cuff tendinopathy as well as 
subacromial impingement syndrome. For this dissertation, we have decided to use the 
term SPS, since it does not implicate any single structure or etiology in the development 
of the syndrome. Rather, SPS is defined as chronic pain that arises from a broad set of 
pathologies localized to the subacromial space. 
The subacromial space, measured on radiographic images as acromiohumeral 
distance, is bound by the greater tuberosity of the humerus inferiorly and the coraco-
acromial arch superiorly (MacDonald et al., 2000). Although the subacromial space is 
small, consisting of 7-14 millimeters in a healthy population (Roberts et al., 2002), it 
houses several crucial soft tissue structures including the subacromial bursa, the tendon 
of the supraspinatus (a rotator cuff muscle) and the tendon of the long head of the biceps. 
Trauma to any or all of the soft tissue structures found in the subacromial space can lead 
to SPS (Michener et al., 2003). Consequently SPS encompasses a number of pathologies 
including bursitis, rotator cuff or bicipital tendinopathies and partial rotator cuff tears. A 
large or complete tear of the rotator cuff is considered a separate disease; however rotator 
cuff tears are often related to SPS in that if left untreated, SPS may progress to a tear. 
Although not every patients with SPS will go on to develop a rotator cuff tear, the long-
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term prognosis for patients with SPS is poor. Roughly 45-50% of patients with shoulder 
pain report persisting pain despite having seen a primary care physician in the previous 
six (Feleus et al., 2007; Kuijpers et al., 2004; Morrison et al., 1997), twelve (Winters et 
al., 1999) or twenty-four months (Cummins et al., 2009).Sex disparities exist among 
populations with shoulder pain in regards to treatment outcomes, with female patients 
experiencing a higher prevalence of repeat injuries and greater levels of disability after 
treatment than male patients (Razmjou et al., 2016, 2011). 
Despite its prevalence, the causes of SPS are still unclear and much debated, 
likely owing to a heterogeneous etiology among patient populations. However, advances 
in research suggest that SPS arises from a complex interaction of risk factors, some of 
which are potentially modifiable through non-surgical means. A large body of recent 
research has found a relationship between specific sensory and motor abnormalities at the 
shoulder joint and the development or progression of SPS (Anderson and Wee, 2011; 
Bandholm et al., 2006; Hidalgo-Lozano et al., 2010); Consistent with many other chronic 
pain conditions, patients with subacromial pain have been found to have hypersensitivity 
(Hidalgo-Lozano et al., 2010; Paul et al., 2012), weakness (MacDermid et al., 2004; 
McCabe et al., 2005) and abnormal proprioception (Anderson and Wee, 2011; Machner 
et al., 2003) at the involved limb and these sensorimotor abnormalities may be 
contributing to the development or progression of SPS. To date however, little work has 
thoroughly examined how standard treatment influences these sensorimotor abnormalities 
in patients with SPS. Additionally, little work has been done to investigate whether these 
sensory and motor deficits arise from the commonly assumed local mechanisms, such as 
the nerves or muscles of the shoulder itself, or central mechanisms within the central 
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nervous system. This is a surprising knowledge gap given that pain is known to exert 
tremendous changes on the sensorimotor system at the central level in other pain 
conditions (Lotze and Moseley, 2007; Lund et al., 1991; Tsay et al., 2015; Woolf, 2011). 
As a result, it is unclear if current treatment practices are capable of rectifying the sensory 
and motor abnormalities found in patients with SPS, or if more targeted intervention 
strategies are warranted. Moreover, it is unknown if sensory and motor abnormalities 
present similarly in male and female patients with SPS, as females have been shown to 
have greater levels of sensory and motor abnormalities in other chronic pain conditions 
(Earle Miller et al., 2016; Speed et al., 2017; Vambheim and Flaten, 2017). Given the 
prevalence, burdens and poor prognosis associated with SPS, especially in the female 
population, these knowledge gaps represent a serious clinical problem that warrants 
further research, and until these knowledge gaps are adequately addressed, advancing 
beyond the current clinical success rate is highly unlikely. 
My dissertation, Sensorimotor Abnormalities in Chronic Subacromial Pain 
Syndrome: The Influence of Sex, Contribution of Pain, and Utility of Using the 
Contralateral Limb as a Control, addresses the aforementioned gaps by comparing the 
sensorimotor abilities of patients with SPS to healthy persons without shoulder pain, both 
before and after standard treatment. By stratifying male and female patients into separate 
groups and assessing the sensorimotor abilities of male and female patients across both 
shoulder joints and remote lower extremities joints, my dissertation provides insight on 
the mechanisms contributing to sensorimotor abnormalities as well as direction for future 
treatment strategies. The overarching goal of this dissertation was to investigate the 
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influence of subacromial pain and sex on sensorimotor abilities, including pain 
sensitivity, proprioception, and strength. 
 
Innovation 
For nearly one out of every two patients, treatment of SPS is inadequate and fails 
to fully resolve symptoms (Cummins et al., 2009). In order to improve the current clinical 
success rate, it is important to understand how certain risk factors, including sensory and 
motor abnormalities, influence the development and progression of SPS. Pain models are 
pivotal for establishing cause and effect relationships, and consequently a battery of pain 
models have been developed to better understand SPS. Similar to research on other 
chronic pain conditions, the pain models developed to study SPS can be divided into 
three distinct categories, including an acute pain-induction model, a longitudinal pain-
relief model, and an acute pain-relief model. While the use of each of these three models 
has elucidated valuable knowledge about the relationships between subacromial pain and 
sensorimotor abnormalities, significant limitations are associated with each model, which 
substantially interfere with the extension of results beyond the model itself and into 
clinically relevant contexts.  
The acute pain-induction model incites temporary pain, either through electrical, 
mechanical or chemical means, into healthy volunteers and compares a subject’s pre-
treatment measures to post-treatment measures (Bajaj et al., 2001). In the context of SPS 
research, acute pain has most frequently been induced in healthy subjects by injecting 
hypertonic saline into the supraspinatus muscle (Bandholm et al., 2008; Diederichsen et 
al., 2009), infraspinatus muscle (Madeleine et al., 2008) or subacromial space 
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(Diederichsen et al., 2009; Stackhouse et al., 2013). Because the acute pain-induction 
model relies on intra-subject comparisons that span a short time interval (minutes to 
hours), this model has been useful for establishing well defined cause-and-effect 
relationships between subacromial pain and sensorimotor abnormalities. Furthermore, the 
pain patterns produced by injecting hypertonic saline into the supraspinatus, infraspinatus 
or subacromial space are strikingly similar to the magnitude and location of pain patterns 
reported in patients with SPS. Despite these similarities in pain patterns, the observed 
effects of experimental shoulder pain on sensorimotor function differ substantially from 
the sensorimotor function observed in patients with SPS (Bandholm et al., 2008; 
Diederichsen et al., 2009; Valencia et al., 2012). Therefore even though an acute pain-
induction model can reflect SPS in terms of pain patterns, it appears unable to reflect the 
adaptations in the central nervous system seen with chronic subacromial pain, as pain 
may need to be present for a longer period of time for such adaptions to occur. 
Substantial discrepancies have been noted between many other chronic pain conditions 
and their associated acute experimental pain models, which questions the validity of 
acute pain-induction models as a whole (Vøllestad and Mengshoel, 2005). 
The longitudinal pain-reduction model is the oldest and most utilized model to 
assess the influence of subacromial pain on sensorimotor function. In this model, patients 
are assessed before and several weeks to years after receiving a treatment intervention 
aimed at reducing the patient’s pain and disability (Dorrestijn et al., 2009; Kuhn, 2009; 
McClure et al., 2004). Because the longitudinal pain-reduction model relies on patient 
measurements before and after treatment, this model has been valuable for establishing 
the effectiveness of specific interventions (such as subacromial decompression surgery, 
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nonsteroidal anti-inflammatory drugs, rehabilitation) on long-term patient outcomes. 
While the longitudinal pain-reduction model has clear relevancy and clinical utility, the 
major limitation to this model is that it does not allow for a cause and effect relationship 
to be established between pain and sensorimotor function. To elaborate, many anatomical 
and environmental changes accompany long-term pain reduction, making it impossible to 
isolate the contribution of pain reduction on sensorimotor function from other variables. 
The first line of treatment for patients with SPS often involves the injection of 
local anesthetics and corticosteroids into the subacromial space, with the anesthetics 
exerting an almost instantaneous reduction in pain in a large percentage of patients. In 
addition to its clinical utility, subacromial injections serve as an invaluable acute pain-
reduction model. By assessing a patient at baseline and 15 minutes following a 
subacromial injection, researchers are able to have a clinically relevant model that uses 
patients while simultaneously controlling for extraneous variables that would occur in a 
longitudinal study and better isolate the influence of pain. While the use of the acute 
pain-reduction model has become increasingly used in research on SPS (Ben-Yishay et 
al., 1994; Ettinger et al., 2014, 2017; Park et al., 2008), it is not without limitations. 
Because patients undergo repeat testing in a short period of time, it is difficult to 
determine whether any changes that occur between the pre-injection and post-injection 
time points are due to a learning effect on the sensorimotor task or true changes in 
sensorimotor function. Fortunately, the use of healthy control population that also 
undergoes repeat testing would allow for a correction of the learning effect, better 
isolating the true influence of subacromial injection in patients. For this dissertation, we 
employed such a method. We feel this approach was innovative because to our 
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knowledge, no previous studies have utilized the acute pain-reduction model in 
conjunction with a control group undergoing repeat testing to investigate the 
influence of subacromial pain on sensory and motor function. 
 
Aims, Hypotheses, and Approach 
As described earlier in the introduction, patients with subacromial pain syndrome 
(SPS) display a number of sensorimotor deficits including hypersensitivity to innocuous 
stimuli, abnormal proprioception, and weakness at the symptomatic limb. The primary 
purpose of this dissertation was to explore whether the aforementioned deficits: (1) can 
be quantified by using the non-involved limb as a measure of control, (2) are purely 
localized to the symptomatic limb or represent a more generalized deficit, (3) are 
influenced by the presence of subacromial pain, and (4) present similarly in male and 
female patients. These purposes were addressed via four specific aims. An overview of 
each specific aim as well as the corresponding hypotheses and methods are provided 
below.  
For Aim 1 (detailed in Chapter II), a cross-sectional study incorporating young 
healthy participants stratified by sex was utilized. For Aim 2, Aim 3, and Aim 4, we 
utilized a single repeated measures study that incorporated both a patient cohort with SPS 
and a healthy control cohort (Chapter III). To specifically address Aim 2 (Chapter IV), 
Aim 3 (Chapter V), and Aim 4 (Chapter VI), subsets of data obtained from patients and 
controls were analyzed from the larger data set. 
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Aim 1 – To investigate whether both males and females display asymmetries at the 
shoulder joint within three sensorimotor modalities: pressure pain sensitivity, 
proprioception, and strength. 
 Hypothesis 1.1 – Pressure pain sensitivity asymmetries would be present in a right 
arm dominant male population but not a right arm dominant female population. 
 Hypothesis 1.2 – Proprioception asymmetries would be present in a right arm 
dominant male population but not a right arm dominant female population. 
 Hypothesis 1.3 – Strength asymmetries would be present in a right arm dominant 
male population but not a right arm dominant female population. 
 
Aim 2 – To assess peripheral sensitization (PS) and central sensitization (CS) by 
testing pain hypersensitivity at involved and remote locations in patients with SPS, 
both before and after acute pain reduction, and to explore characteristics associated 
with the presence of CS. 
 Hypothesis 2.1 – Patients with SPS would demonstrate a greater sensitivity to 
pain at the symptomatic shoulder and remote locations (contralateral shoulder, 
both knees) than matched controls. 
 Hypothesis 2.2 – Upon pain reduction, patients experiencing SPS would 
demonstrate decreased sensitivity to pain at both shoulders and both knees 
relative to pre-injection values. 
 Hypothesis 2.3 – After controlling for pain duration and pain intensity, female 
patients would demonstrate greater sensitivity than male patients. 
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Aim 3 – To assess regional and global abnormalities to proprioceptive function by 
testing joint position sense at involved and remote locations in patients with SPS, 
both before and after acute pain reduction, and to explore characteristics associated 
with the presence of abnormal proprioception.  
 Hypothesis 3.1 – Patients experiencing SPS would demonstrate worse 
proprioception at the symptomatic shoulder as well as remote joints (contralateral 
shoulder, both knees) than matched controls. 
 Hypothesis 3.2 – Upon pain reduction, patients experiencing SPS would 
demonstrate worse proprioception both shoulders and both knees relative to pre-
injection values.  
 Hypothesis 3.3 – After controlling for pain duration and pain intensity, female 
patients would demonstrate greater proprioceptive errors than male patients. 
 
Aim 4 – To assess regional and global weakness by testing peak isometric torque at 
involved and remote locations in patients with SPS, both before and after acute pain 
reduction, and to explore characteristics associated with weakness. 
 Hypothesis 4.1 – Patients with SPS would demonstrate smaller peak torque values 
at the symptomatic shoulder and remote locations (contralateral shoulder, both 
knees) than matched controls. 
 Hypothesis 4.2 – Upon pain reduction, patients experiencing SPS would 
demonstrate greater peak torque values at both shoulders and both knees relative 
to pre-injection values. 
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 Hypothesis 4.3 – After controlling for pain duration and pain intensity, female 
patients would demonstrate smaller normalized peak torque than male patients.  
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CHAPTER II 
 
THE INFLUENCE OF SEX ON SENSORIMOTOR ASYMMETRIES 
 
The experiment described in this chapter was developed with Dr. Andrew 
Karduna who contributed substantially to this work by assisting with experimental 
conception, editing and advising throughout the project. I was the primary contributor to 
the development of the experimental design, data collection and analysis, and write up. 
 
Introduction 
Localized hypersensitivity to pain, abnormal proprioception, and weakness have 
been found in persons with subacromial pain syndrome (SPS), and are thought to play a 
role in the progression or development of this pathology. Consequently, these sensory 
and motor abnormalities have become important areas of interest for clinicians and 
researchers (Ettinger et al., 2017; Littlewood et al., 2013). Pain sensitivity, proprioceptive 
function, and weakness are frequently assessed in patients with SPS by comparison with 
their uninjured contralateral shoulder (Coronado et al., 2011; Machner et al., 2003; 
McCabe et al., 2005; Potzl et al., 2004; Tyler et al., 2005). That is, deficits and 
subsequent treatment strategies are calculated from the assumption that prior to injury, a 
patient’s shoulders demonstrated bilateral symmetry. The scientific assumption of this 
practice needs further clarification as significant asymmetries in pain sensitivity, 
proprioception, and strength may exist in healthy shoulders, and these asymmetries may 
be particularly evident in males versus females (Adamo et al., 2012). If the shoulders of 
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healthy males or females demonstrate asymmetries in pain sensitivity, proprioception or 
strength, this finding questions the validity of using a patient’s uninjured shoulder as a 
control, particularly in research settings where a control group could be incorporated into 
the study design. 
The lateralization of brain function has been well demonstrated, such that some 
functions tend to be localized to one of the two hemispheres (Hugdahl, 2011). For 
example, the left hemisphere has been associated with language functions, while the right 
hemisphere is associated with visual spatial tasks. With respect to motor control, the 
cerebral hemispheres demonstrate contralateral sensorimotor control, with the left arm 
and leg being controlled by the right hemisphere and the right arm and leg being 
controlled by the left hemisphere. In general, females show less cerebral lateralization 
than males (Wisniewski, 1998). Initial observations on sex related differences in 
lateralization emerged from studies on vision and hearing, which revealed that females 
demonstrated less lateralization in response to visual and auditory stimuli than males 
(Hiscock et al., 1995; Voyer, 1996). Later studies have probed sex differences in the 
lateralization of motor control, and showed females displayed a greater amount of 
bilateral activation and interhemispheric communication in response to sensorimotor 
stimuli (Stephen et al., 2006). It has been suggested that less lateralization and greater 
interhemispheric communication may arise from the larger corpus callosum present in 
females (Allen et al., 1991). 
While neuroimaging studies have shown that males demonstrate greater 
lateralization in portions of the brain associated with sensorimotor control than females, 
few studies have been developed to assess sex differences in asymmetries during 
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functional sensorimotor tasks. A vast number of studies have compared pain sensitivity, 
proprioception, and strength between the dominant and non-dominant upper extremity, 
without controlling for sex. However, the literature on differences in pain sensitivity, 
proprioception, and strength between the dominant and non-dominant upper extremity is 
contradictory. Some studies have found that the dominant limb of healthy right handers 
displayed less pain sensitivity (Ozcan et al., 2004; P Pauli et al., 1999; Paul Pauli et al., 
1999) , greater strength (Cahalan et al., 1991; Lertwanich et al., 2006; Perrin et al., 1987) 
and greater proprioceptive errors (Bagesteiro and Sainburg, 2002; Goble and Brown, 
2008) than the non-dominant limb, while nearly just as many studies have found no 
difference in pain sensitivity (Kindler et al., 2011; Rolke et al., 2006; Sacramento et al., 
2017), strength (Gołebiewska et al., 2008; Ivey et al., 1985; Mattiello-Rosa et al., 2008), 
and proprioception (King et al., 2013; Voight et al., 1996) between the limbs. Part of this 
discrepancy may arise from the fact that few studies have statistically or experimentally 
accounted for sex when assessing sensorimotor asymmetries. Many of the 
aforementioned studies utilized an all-male cohort of participants, while other studies 
were skewed towards female majority cohorts. A recent study by Adamo et al. (2012) 
investigated elbow proprioception while age matching men and women into separate 
cohorts. These authors found that asymmetries in proprioception were only present in 
males, and advocated for researchers to consider sex in sensorimotor control studies, 
especially when comparing the dominant and non-dominant upper extremities, since sex 
dependent asymmetries may be present in other joints as well. 
In order to assess whether it is appropriate to use the non-involved limb as a 
measure of control for pain sensitivity, proprioception, and strength in both men and 
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women, additional studies exploring whether asymmetries are present in both males and 
females are clearly needed. Such information might not only be useful in the context SPS, 
but for other upper extremity disorders, such as stroke or chronic regional pain syndrome. 
The aim of this study was to investigate whether both males and females 
display asymmetries at the shoulder joint within three sensorimotor modalities: 
pressure pain sensitivity, proprioception, and strength. We hypothesized that 
pressure pain sensitivity (Hypothesis 1.1), proprioception (Hypothesis 1.2), and 
strength (Hypothesis 1.3) asymmetries would be present in a right arm dominant 
male population but not a right arm dominant female population.. 
 
Methods 
Participants 
 
Twenty-seven uninjured female and twenty-seven uninjured male participants 
were included in the present study (Table 2.1). All participants were right-arm dominant 
and between the ages of 18-35 years. Right-arm dominance was defined as a score 
greater than or equal to 80 on the modified Edinburgh Handedness Inventory (Oldfield, 
1971). Exclusion criteria were: 1) current pain across the upper extremity; 2) history of 
surgery, traumatic injury, instability or arthritis to the shoulder, elbow or wrist; 3) current 
participation in a vigorous overhead activity; 4) a diagnosed chronic pain or neurological 
disorder; 5) current or past use of gonadal hormones opposite to biological sex; and 6) 
pregnancy. All participants were informed about the purpose and protocol of the project 
and gave their written informed consent prior to participation in the study. All 
experimental conditions were approved by the Institutional Review Board. 
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Table 2.1. Characteristics (means ± SDs) of male and female participants enrolled in the 
asymmetry study.  
 
  Males  Females  
      
Age (years)  24 ± 4  22 ± 4  
Edinburgh Handedness Inventory 
(0-100) 
 96 ± 5  98 ± 4  
Height (cm)  179 ± 6  167 ± 6*  
Weight (kg)  78 ± 13  66 ± 12*  
BMI  24 ± 4  24 ± 4  
      
* Denotes a significant difference between male and female participants. 
 
 
 
Study Design 
 
The present study used a cross-sectional design with male and female participants 
divided into separate groups. After obtaining informed consent, participants engaged in 
the bilateral sensory and motor tasks in the following order: proprioception, strength, and 
pain sensitivity. The side selected to be tested first (dominant or non-dominant) was 
randomized and counter-balanced. Data collection was completed in one session. 
 
 
Pain Sensitivity 
 
Pain sensitivity was tested at both shoulders utilizing a pressure pain threshold 
(PPT) protocol. Measures of PPT, defined as the minimum force applied that induced 
pain (Fischer, 1987), were obtained with the use of a hand-held pressure algometer with a 
one-cm2 probe (Wagner Instruments). With participants in a seated position, upper 
extremity assessment sites were marked at the bilateral deltoid and infraspinatus muscles. 
The deltoid location was marked at the midpoint between the flat portion of the acromion 
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and deltoid insertion (Figure 2.1). The infraspinatus location was marked at the midpoint 
between the inferior angle of the scapula and midpoint of the scapular spine (Figure 2.1).  
The researcher positioned the probe perpendicular to the assessment site and 
applied progressive pressure at a rate of approximately one kg/s. The participant was 
instructed to inform the assessor when they first perceived a sensation of pain or 
discomfort, at which point pressure application ceased and the PPT value was noted. 
The order of testing (location and side) was blocked and randomized between 
participants. Four measurements were obtained for each location with a 30 second 
interval between measurements. The four trials were averaged to obtain one raw PPT 
score for the right shoulder (X̅PPT.Right) and one raw PPT score for the left 
shoulder(X̅PPT.Left). Previous investigations have consistently shown that males have 
significantly larger PPT scores than females (Neziri et al., 2011). Consequently, the 
following normalization calculation was utilized to calculate PPT asymmetry scores:  
2.1 
PPT Asymmetry Index ( % ) =
X̅PPT.Right−X̅PPT.Left
(X̅PPT.Right + X̅PPT.Left) 2⁄
 x 100% 
Using this formula, a value of 0 indicates perfect symmetry was present between the right 
and left sides while a positive value indicates the right limb required more pressure to 
induce pain sensation than the left limb. 
 
 
Proprioception 
 
Proprioception at both shoulders was assessed utilizing an active-active joint 
position sense (JPS) protocol. Measurements were obtained by affixing a 5th generation 
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iPod Touch to the lateral aspect of the humerus, approximately two inches above the 
elbow joint via an elastic band (Figure 2.2). The iPod ran on a custom developed app that 
emitted auditory cues and calculated joint angles with respect to gravity utilizing data 
from the tri-axial accelerometer and tri-axial gyroscope. The validity of the app has 
previously been validated in a field setting and compared to a similar protocol involving 
an electromagnetic tracking device(S. Edwards et al., 2016).  
Each JPS trial consisted of an active positioning phase followed by an active 
repositioning phase. The following is an explanation of each phase of a JPS trial. 
1. Baseline position – At the beginning of the trial, the participant assumed a 
relaxed baseline position. 
2. Positioning phase – The positioning phase began with a low-pitched sound, 
prompting the participant to leave the baseline position. The pitch (or frequency) of the 
auditory tone provided the participant with feedback about the angle of their joint relative 
to the target. When the participant attained the target (defined as ± 3˚from the desired 
joint angle) the participant was directed to hold the target position and memorize its 
location. After holding the target for three seconds, the participant returned to the 
baseline position and then held the baseline position for one second. 
3. Repositioning phase – Without auditory feedback from the app, the participant 
repositioned their joint away from baseline and into the previously memorized target. 
After maintaining a static position (defined as velocity less than 0.25 degrees/sec) for one 
second, the device recorded the participant’s position. 
During testing, participants were seated with their eyes closed. To minimize 
extraneous cues across the upper extremity, females wore sleeveless shirts or sports bras 
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while males wore sleeveless shirts or no shirt. Prior to data collection, participants 
performed several practice trials at non-test angles to become acquainted with the 
protocol. The number of practice trials varied by participant and was determined by the 
researcher based on the participant’s competency with the protocol. 
Assessment of the shoulder involved shoulder flexion performed in the sagittal 
plane while seated in a backless chair. During all testing, the participant was instructed to 
keep the elbow locked in extension and the thumb pointed upwards. The targets of 
interest for the shoulder were 70 degrees of shoulder flexion, presented three times per 
joint. Two distractor targets of 55 and 85 degrees were also presented. Distractor targets 
were utilized to ensure participants did not memorize the target of interest. The testing of 
sides was randomized and counterbalanced between participants. 
After data collection, each trial was analyzed with custom written LabVIEW 
(National Instruments, Austin, TX) software. The difference between the repositioned 
angle and presented angle was termed repositioning error. If the repositioned angle 
involved greater excursion than the target angle this was called an overestimation and 
given a positive sign. The repositioning error for each of the three trials at 70 degrees was 
then used to calculate three raw error scores for each joint: absolute error (AE), constant 
error (CE) and variable error (VE). 
1. Absolute Error (AE) – this was defined as the mean of the absolute 
repositioning errors or overall deviation error. Absolute errors represent accuracy 
without considering directional bias. Larger values indicate larger errors. 
2. Constant Error (CE) – this was defined as the mean of repositioning errors. 
Constant errors represent accuracy with directional bias and were calculated as 
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defined by Schmidt and Lee (Schmidt and Lee, 1999). A positive value for CE 
indicates greater joint excursion occurred during the repositioning phase relative 
to the presented phase and a negative value indicates smaller joint excursion 
occurred during the repositioning phase relative to the presented phase. 
3. Variable Error (VE) – this was defined as the population standard deviation 
from the mean of constant errors. Variable errors represent the ability of 
participants to consistently sense test positions and were calculated as defined by 
Schmidt and Lee (Schmidt and Lee, 1999). Larger values indicate larger 
variability in repositioning errors between trials. 
Previous investigations have not established that males and females have different 
proprioceptive abilities as measures by AE, CE, or VE scores (Ángyán et al., 2007; 
Bjorklund et al., 2000). Consequently proprioceptive asymmetry scores were calculated 
for AE, CE, and VE without a normalization procedure according to the following 
formulas: 
2.2 
AE Asymmetry (degrees)  = X̅AE.Right − X̅AE.Left  
2.3 
CE Asymmetry (degrees) = X̅CE.Right − X̅CE.Left  
2.4 
VE Asymmetry (degrees) = X̅VE.Right − X̅VE.Left  
Using these conventions, a value of 0 for AE Asymmetry or VE Asymmetry indicates 
perfect symmetry was present between the right and left sides while a positive value 
indicates the right limb presented with larger errors than the left side. A value of 0 for  CE 
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Asymmetry indicates perfect symmetry was present between the right and left sides while 
a positive value indicates the right limb repositioned to a more flexed angle than the right 
side.  
 
Strength 
 
Strength at both shoulders was assessed utilizing a maximum isomeric voluntary 
contractions (MVIC) protocol. Measurements were obtained from a computerized system 
consisting of a uniaxial load cell, amplifier, and data acquisition unit running on custom 
written LabVIEW (National Instruments, Austin, TX) software. Graphical representation 
of contraction force was visible on a monitor in real time to research personnel but not 
participants. Data were sampled at 1000 Hz and recorded as force. For each joint, the 
peak (or maximum) force produced out of the series of three trials was used for data 
analysis.   
The testing procedure was strictly standardized, including participant positioning, 
contraction time, rest time between trials, number of trials per side, and verbal instruction 
and encouragement. Maximum isometric volunteer contractions were performed against 
resisted sagittal plane flexion of the upper extremity, with the shoulder in 90 degrees of 
flexion, the elbow in full extension and the forearm in neutral pronation/supination. 
Participants were in a seated position and the trunk was stabilized with straps (Figure 
2.3). The load cell was mounted to a metal testing frame and positioned just proximal to 
the styloid process of the radius. Each joint was tested three times, with thirty seconds of 
rest in between each trial. The testing of sides was randomized and counterbalanced 
between participants. Participants were verbally encouraged by the investigator during 
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each muscle contraction and instructed to continue the contraction for five seconds. 
Feedback about performance was not given to participants.  
For each joint, the peak force score (N) was converted to a peak torque score 
(Nm). To calculate peak torque, peak force was multiplied by the moment arm (defined 
as the distance between the center of the shoulder joint and the center of the load cell). 
The moment arm length was measured with a seamstress ruler from the center of the 
shoulder joint to the middle of the point of contact with the load cell. One peak torque 
was obtained for the right shoulder (X̅Torque.Right) and one peak torque score was 
obtained for the left shoulder (X̅Torque.Left). Previous investigations have consistently 
shown that males are significantly stronger than females (Bishop et al., 1987; Hoffman et 
al., 1979). Consequently, the following normalization calculation was utilized to calculate 
torque asymmetry scores:  
2.5 
Torque Asymmetry Index (% ) =
X̅Torque.Right − X̅Torque.Left
(X̅Torque.Right + X̅Torque.Left) 2⁄
x 100% 
Using this formula, a value of 0 indicates perfect symmetry was present between the right 
and left sides while a positive value indicates the right limb produced greater torque than 
the left side.  
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Figure 2.1. Experimental set-up used for pressure pain threshold (PPT) measurements 
during the asymmetry study. A) Deltoid location. B) Infraspinatus location.  
 
 
Statistical Analysis 
 
SPSS version 22 (IBM, Chicago, IL) was used for all statistical analysis. Values 
of p < 0.05 were regarded as statistically significant for all analysis.  
 
Between-Group Demographics - To assess whether differences in demographics 
and anthropometrics were present between male and female participants, a series of 
independent t-tests were run.  
 
Hypothesis 1.1 – Asymmetries in pressure pain sensitivity would be present 
in a right-arm dominant male population but not a right-arm dominant female 
population. Before addressing the hypothesis, we first tested whether males presented 
with significantly larger raw PPT scores than females by running an independent sample 
t-tests. Sex was the independent variable and average raw PPT score (expressed in kg and 
A B 
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Figure 2.2. Experimental set-up used for proprioception measurements during the 
asymmetry study. A) Shoulder in rest position. B) Shoulder in reaching position.  
 
 
 
Figure 2.3. Experimental set-up used for peak torque (strength) measurements during the 
asymmetry study. 
A B 
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collapsed across the right and left sides) was the dependent variable. If significant 
differences were found between male and female participants raw PPT scores, all 
subsequent analyses were run with PPT Asymmetry Index scores as the dependent 
variable for normalization purposes.  
To address our hypothesis, three one-sample t-tests were run with the following 
test variables against a sample value of 0: (1) PPT Asymmetry Index for males only, (2) 
PPT Asymmetry Index for females only, and (3) PPT Asymmetry Index for males and 
females pooled into one population. In addition, to determine if the magnitudes of PPT 
asymmetries were different between males and females, one independent-sample t-tests 
was run. The independent variable was sex (male, female) and the dependent variable 
was PPT Asymmetry Index. This entire procedure was repeated twice: once for the 
infraspinatus location and once for the deltoid location. 
 
Hypothesis 1.2 – Asymmetries in proprioception would be present in a right-
arm dominant male population but not a right-arm dominant female population. 
Before addressing the hypothesis, we first tested whether males and females 
demonstrated similar raw AE scores by running an independent sample t-test. Sex was 
the independent variable and average raw AE score (expressed in degrees and collapsed 
across the right and left sides) was the dependent variable. If no significant differences 
were found between male and female participants raw AE scores, all subsequent analyses 
were run with AE Asymmetry scores as the dependent variable, since normalization was 
not necessary. 
To address our hypothesis, three one-sample t-tests were run with the following 
test variables against a sample value of 0: (1) AE Asymmetry for males only, (2) AE 
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Asymmetry for females only, and (3) AE Asymmetry for males and females pooled into 
one population. In addition, to determine if the magnitude of proprioceptive asymmetries 
were different between males and females, one independent-sample t-tests was run. The 
independent variable was sex (male, female) and the dependent variable was AE 
Asymmetry. This entire procedure was repeated twice more: once for CE scores and once 
for VE scores. 
 
Hypothesis 1.3 – Asymmetries in strength would be present in a right-arm 
dominant male population but not a right-arm dominant female population. Before 
addressing the hypothesis, we first tested whether males presented with significantly 
larger raw torque scores than females by running an independent sample t-tests. Sex was 
the independent variable and average raw torque score (expressed in Nm and collapsed 
across the right and left sides) was the dependent variable. If significant differences were 
found between male and female participants raw torque scores, all subsequent analyses 
were run with Torque Asymmetry Index scores as the dependent variable for 
normalization purposes. 
To address our hypothesis, three one-sample t-tests were run with the following 
test variables against a sample value of 0: (1) Torque Asymmetry Index for males only, 
(2) Torque Asymmetry Index for females only, and (3) Torque Asymmetry Index for 
males and females pooled into one population. In addition, to determine if the magnitude 
of asymmetries were different between males and females, one independent-sample t-
tests was run. The independent variable was sex (male, female) and the dependent 
variable was Torque Asymmetry Index. 
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Results 
 
Participant Characteristics 
 
Independent t-tests revealed no significant differences between male and female 
participants in regards to age (p=0.08), BMI (p=0.79), or Edinburgh Handedness Scores 
(p=0.13). Independent t-test revealed significant differences in height (p<0.01) and 
weight (p<0.01), with males being taller and heavier (Table 2.1). 
 
Pain Sensitivity: Hypothesis 1.1 
 
For both the infraspinatus (p=0.001) and deltoid (p<0.001) locations, males 
demonstrated significantly larger raw PPT scores than females. Based on this finding, 
subsequent analyses were run using PPT Asymmetry Index scores as the dependent 
variable for normalization purposes. Raw PPT score values are presented in Table 2.2. 
In the male-only population, both the deltoid (p=0.001) and infraspinatus 
(p<0.001) demonstrated PPT Asymmetry Indexes that were significantly different than 0. 
Males mean PPT Asymmetry Indexes were 6-7%, indicating that the right limb 
experienced 6-7% more pressure compared to the left limb (Figure 2.4). In the female-
only population, neither the deltoid (p=0.15) nor infraspinatus (p=0.06) demonstrated 
PPT Asymmetry Indexes that were significantly different from 0, despite mean values of 
3-5% (Figure 2.4). When males and females were pooled into one mixed-sex population, 
both the deltoid (p=0.001) and infraspinatus (p<0.001) were found to have PPT 
Asymmetry Indexes that were significantly different from 0, with mean values of 5-6% 
(Figure 2.4). When males and females were compared to each other, no significant group 
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differences in PPT Asymmetry Indexes were found at either the deltoid (p=0.63) nor 
infraspinatus (p=0.28). 
 
 
 
Figure 2.4. PPT Asymmetry Index scores (means ± SEMs) for male and female 
participants. A) Deltoid location. B) Infraspinatus location. *Denotes value is 
significantly different from 0. 
 
 
 
Proprioception: Hypothesis 1.2 
 
No significant differences were found between male and female subjects in 
regards to AE (p=0.18), CE (p=0.31) or VE (p=0.49) scores. Based on this finding, a 
normalization procedure was not needed and subsequent analyses were run using AE 
Asymmetry, CE Asymmetry, and VE Asymmetry scores. Raw AE, CE, and VE values 
are presented in Table 2.2. 
In the male-only population, AE Asymmetry (p=0.03), CE Asymmetry (p=0.02), 
and VE Asymmetry (p=0.04) scores were significantly different than 0 (Figure 2.5). 
Males mean AE Asymmetry scores were 0.9 degrees, indicating that AE scores were 0.9 
degrees larger at the right side compared to the left. Males mean CE Asymmetry scores 
were 1.2 degrees, indicating that repositioning errors at the right limb were located 1.2 
A B 
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degrees more flexed than left limb repositioning errors. Males mean VE Asymmetry 
scores were -0.6 degrees, indicating that indicating that VE scores were 0.6 degrees larger 
at the left side compared to the right (Figure 2.5). In the female-only population, neither 
AE Asymmetry (p=0.08), CE Asymmetry (p=0.33) nor VE Asymmetry (p=0.88) scores 
were significantly different than 0 (Figure 2.5). Mean AE Asymmetry, CE Asymmetry, 
and VE Asymmetry scores were equal to 0.4 degrees, 0.3 degrees and 0.0 degrees, 
respectively in the female population. When males and females were pooled into one 
mixed-sex population, both AE Asymmetry (p<0.001) and CE Asymmetry (p=0.001) 
scores were found to be significantly different than 0 while VE Asymmetry (p=0.30) 
scores were not found to be significantly different than 0 (Figure 2.5). When males and 
females were compared, no significant group differences in scores were found at for AE 
Asymmetry (p=0.29), CE Asymmetry (p=0.13) or VE Asymmetry (p=0.15) scores 
 
Strength: Hypothesis 1.3 
 
Males were found to have significantly larger raw torque scores than females 
(p<0.001). Based on this finding, subsequent analyses were run using the Torque 
Asymmetry Index as the dependent variable for normalization purposes. Raw torque 
score values are presented in Table 2.2. 
In the male-only population, the shoulders demonstrated a Torque Asymmetry 
Index that was not significantly different from 0 (p=0.69). Males mean Torque 
Asymmetry Index was 1%, indicating that torque values produced on the right side were 
1% larger than the left side (Figure 2.6). In the female-only population, the shoulders 
demonstrated a Torque Asymmetry Index that was significantly different than zero 
(p=0.03), with a mean of 5% (Figure 2.6). When males and females were pooled into one 
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mixed-sex population, the shoulders were found not to have a Torque Asymmetry Index 
significantly different from 0 (p=0.06), despite a mean of 3% (Figure 2.6). When males 
and females were compared to each other, no significant group differences in Torque 
Asymmetry Indexes were found (p=0.17). 
 
 
  
 
 
Figure 2.5. Proprioception Asymmetry scores (means ± SEMs) for male and female 
participants. A) Absolute errors. B) Constant errors. C) Variable errors. *Denotes value is 
significantly different from 0. 
 
 
 
 
A B 
C 
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Figure 2.6. Torque Asymmetry Index scores (means ± SEMs) for male and female 
participants. Positive values indicate larger torque was exerted by the right versus left 
side. *Denotes value is significantly different from 0. 
 
 
 
 
 
Table 2.2. Raw (means ± SDs) pressure pain threshold (PPT), proprioception, and peak 
torque (strength) scores for male and female participants enrolled in the asymmetry 
study.  
 Males Females 
 Dominant Non-
dominant 
Dominant Non-
dominant 
     
PPT     
Deltoid (kg) 3.6 ± 1.4 3.4 ± 1.4 2.4 ± 0.9 2.2 ± 0.8 
Infraspinatus (kg) 3.9 ± 1.9 3.6 ± 1.7 2.5 ± 0.9 2.4 ± 0.9 
     
Proprioception     
AE (degrees) 4.1 ± 2.8 3.2 ± 2.7 3.0 ± 1.8 2.7 ± 1.8 
CE (degrees) 3.6 ± 3.5 2.4 ± 3.5 2.4 ± 2.7 2.0 ± 2.4 
VE (degrees) 1.8 ± 1.0 2.4 ± 1.2 1.9 ± 1.1 1.9 ± 1.4 
     
Strength     
Shoulder Flexion 
(Nm) 
56.3 ± 12.2 29.6 ± 7.3 56.0 ± 13.4 27.9 ± 6.0 
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Discussion 
The aims of the present study were to investigate whether both males and females 
display asymmetries at the shoulder joint within three sensorimotor modalities, including 
pressure pain sensitivity, proprioception, and strength. We hypothesized that asymmetries 
in pressure pain sensitivity, proprioception, and strength would be present in a right-arm 
dominant male population but not a right-arm dominant female population. The results 
corresponding to each sensorimotor modality are discussed below. 
Our hypothesis that asymmetries in proprioception would be present in a right-
arm dominant male population but not a right-arm dominant female population was 
supported. Males demonstrated proprioception asymmetry scores that were significantly 
different from 0 within all three metrics of proprioception, AE, CE, and VE. Specifically, 
the non-dominant limb of male participants demonstrated better repositioning accuracy 
than the dominant limb by ~0.9 degrees, due to a smaller overshooting bias and more 
variable pattern at the non-dominant limb. These results fit well with previous literature 
which is currently split as to whether the non-dominant limb has a proprioceptive 
advantage (Bagesteiro and Sainburg, 2002; Goble and Brown, 2008) or no asymmetries 
are present (King et al., 2013; Voight et al., 1996). Specifically, a recent systematic 
review article by our lab investigated the effects of arm dominance on shoulder 
proprioception (Conner et al., 2017). Six of the articles meeting inclusion criteria had 
results showing a non-dominant limb advantage while another twenty articles found no 
evidence for asymmetries. Based on the results of the review, there is likely an 
underlying effect of arm dominance that is small and is being obscured by confounding 
variables. Since a sex effect was not investigated in many other studies looking at 
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proprioceptive asymmetries, and the present study found a significant non-dominant limb 
advantage for males only, it is possible that the conflicting results from earlier studies 
could have reflected the proportion of male/female participants (Adamo et al., 2012). 
Similar to our results on proprioception, our hypothesis that asymmetries in 
pressure pain sensitivity would be present in a right-arm dominant male population but 
not a right-arm dominant female population was also supported. Across both shoulder 
locations (deltoid and infraspinatus), males demonstrated PPT asymmetry scores that 
were significantly different from 0, with 6-7% greater pressure being tolerated by the 
dominant versus non-dominant limb. In contrast, females PPT asymmetry scores at both 
shoulder locations were not significantly different from 0, despite 3-5% greater pressure 
being tolerated by the dominant versus non-dominant limb. Like our results on 
proprioception, these results fit well with previous literature which is currently split as to 
whether the non-dominant limb has greater sensitivity to pain than the dominant limb 
sensitivity (Ozcan et al., 2004; P Pauli et al., 1999; Paul Pauli et al., 1999) or no 
asymmetries are present (Kindler et al., 2011; Rolke et al., 2006; Sacramento et al., 
2017). To our knowledge, no systematic reviews have been conducted to detail the 
number of studies that have looked at the effect of arm dominance on pain sensitivity. 
Since a sex effect was not investigated in many other studies looking at PPT 
asymmetries, and the present study found a significant non-dominant limb advantage for 
males only, it is possible that the conflicting results from earlier studies could have 
reflected the proportion of male/female participants. The small sample size of some 
previous studies could also contribute to the lack of a dominance effect. 
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Our last hypothesis that asymmetries in strength would be present in a right-arm 
dominant male population but not a right-arm dominant female population was not 
supported. While both males and females exerted greater peak torque across the right 
versus left shoulder, these asymmetries only reached significance in the female (mean 
5%) but not male population (mean 1%). Previous literature is currently split as to 
whether the dominant limb is stronger than the non-dominant limb (Cahalan et al., 1991; 
Lertwanich et al., 2006; Perrin et al., 1987) or no asymmetries are present (Gołebiewska 
et al., 2008; Ivey et al., 1985; Mattiello-Rosa et al., 2008). To our knowledge, no 
systematic reviews have been conducted to detail the number of studies that have looked 
at the effect of arm dominance on strength. Much of the discrepancy in previous literature 
may have to do with the varied protocols and populations (athletes versus non-athletes) 
that have been used to assess strength. However since a sex effect was not investigated in 
many other studies looking at strength asymmetries, and the present study found a 
significant dominant limb advantage for females only, it is possible that the conflicting 
results from earlier studies could have reflected the proportion of male/female 
participants. The small sample size of some previous studies could also contribute to the 
lack of a dominance effect. 
It is interesting to note that in both of our sensory measures, proprioception and 
pressure pain threshold, it was the non-dominant limb of males that demonstrated a 
heightened sense of touch and position. The dynamic dominance hypothesis of 
handedness is gaining increasing acceptance as an explanation for upper extremity 
asymmetries and may explain the non-dominant limb advantage noted in our 
proprioception and pressure pain measures (Sainburg, 2002). The dynamic dominance 
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hypothesis states that the dominant limb/non-dominant hemisphere specializes in 
performing dynamic movements while the non-dominant limb/dominant hemisphere 
specializing in holding static postures. Such roles for the upper extremities are evident in 
many activities of daily living where the dominant arm manipulates an object in the 
visual field while the non-dominant limb stabilizes it without the aid of vision. A 
heightened sense of arm position and sensitivity to pain in the non-dominant limb as 
noted in the present study seems advantageous for protecting the non-dominant limb from 
harm in the absence of vision. 
Although it is difficult to determine the origin of larger sensory asymmetries in 
males versus females, some insight may be provided by a combination of structural and 
physiological differences associated with sex. Specifically, females demonstrate less 
lateralization as imaging studies have shown greater interhemispheric interactions and 
bilateral activation patterns in females versus males (Rabinowicz et al., 2002; 
Wisniewski, 1998). Functionally, females also demonstrate less lateralization during 
visual or auditory tasks (Hiscock et al., 1995). That strength asymmetries were more 
pronounced in females as opposed to males was a surprising finding. The degree to which 
repeated use or a genetically inheritable trait contributes to asymmetries is more difficult 
to ascertain with strength. 
By finding significant asymmetries between the dominant and non-dominant limb 
among healthy controls in three sensorimotor modalities, our results suggest that using a 
patient’s uninjured contralateral shoulder to quantify sensorimotor deficits may be 
inappropriate, especially in research settings where a control group could be incorporated 
into the analysis. Depending upon the side (dominant versus non-dominant) that is 
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injured, sensorimotor deficits could be artificially inflated or masked by solely relying on 
values obtained from the injured limb. Since the development of normative asymmetry 
indexes is beyond the scope of the present study, the use of a control population may be 
preferable when assessing sensorimotor modalities in clinical populations in research 
settings. Moreover, since the present study found sensorimotor asymmetries to be sex 
dependent, it is also important to sex match controls to clinical populations. 
There are several limitations to the present study. The first limitation concerns the 
fact that shoulder sensorimotor tasks were performed in limited positions. For example, 
proprioception was only assessed with a flexion task; however it is possible that different 
motions such as abduction, external/external rotation, etc. could yield different results. 
Similarly, strength was only assessed at 90 degrees of flexion, and other positions and 
motions could also yield different results. Another limitation is that only a young 
population (18-35 years) was evaluated in this study, therefore our results cannot be 
reliably extended to older populations. It is possible that as persons age, sensorimotor 
asymmetries present differently. The use of two populations (young and older) could 
have helped account for this. Also, there is likely a difference in asymmetries between 
right and left-arm dominant persons. 
 
Conclusions 
The present study found that asymmetries in three sensorimotor modalities, 
pressure pain threshold, proprioception, and strength, did not present uniformly in male 
and female participants at the shoulder joint. Specifically, male participants exhibited 
significant asymmetries in the two sensory modalities, pressure pain threshold and 
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proprioception, while females did not. Males’ sensory asymmetries tended to favor 
greater sensitivity in the non-dominant limb. In contrast, female participants exhibited 
significant asymmetries in the motor modality, strength, while males did not. Females’ 
motor asymmetries favored greater strength in the dominant versus non-dominant limb. 
Taken together, these findings suggest sex may be an important variable of consideration 
when comparing the dominant to non-dominant limb or healthy to injured limb. 
Moreover, it may be inappropriate to use the healthy limb as a measure of control 
researcher studies looking at populations with shoulder injuries. 
 
Bridge 
In the present study (Chapter II), for shoulders of a young uninjured population, 
asymmetries in pain sensitivity, proprioception, and strength were found to be present 
and sex dependent. These finding suggest that when assessing sensorimotor modalities 
in populations with shoulder injuries, the healthy limb may be an inadequate reference 
as a control.  Consequently, as we designed our next study, as outlined in Chapter III, we 
built on the findings of the present study by including a control group that was tightly 
matched for arm dominance, sex, and age to serve as a reference when evaluating 
sensorimotor deficits in patients with chronic shoulder pain.  
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CHAPTER III 
 
STUDY DESIGN AND RESULTS COMMON TO AIM 2, AIM 3, and AIM 4 
 
 The experiment described in this chapter was developed with Dr. Andrew 
Karduna who contributed substantially to this work by assisting with experimental 
conception, editing and advising throughout the project. Dr. Matthew Shapiro further 
contributed to the study by assisting in recruiting patients with subacromial pain and 
performing the subacromial injection. I was the primary contributor to the development 
of the experimental design, data collection and analysis, and write up. 
 
General Procedures 
 
To address Aim 2 (Chapter IV), Aim 3 (Chapter V), and Aim 4 (VI), which all 
center on a patient population with chronic subacromial pain, we developed one large 
study which is detailed in this chapter.  The methods and results shared in the present 
chapter are common to Aim 2, Aim 3, and Aim 4.  Then in the next three chapters 
(Chapters IV – VI), we analyzed specific subsets of the data that pertained to each aim.   
The present study used a repeated-measures design with two participant groups: 
(1) patients with subacromial pain syndrome and (2) uninjured controls. Both patient and 
control participants were tested at two time points. For patient participants, the two time 
points included immediately prior to and fifteen minutes after receiving a subacromial 
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injection. For control participants, the two time points were separated by a fifteen minute 
rest period (Figure 3.1).  
Self-reported measures, including information about health history, demographics 
and Disability of the Arm, Shoulder and Hand (DASH) scores were obtained once prior 
to session 2. Instrumented measures including Visual Analog Scale (VAS), pain 
sensitivity, proprioception, and strength testing were obtained twice, once prior and once 
after the injection/rest period.  For Aim 2, we looked at the data pertaining to pain 
sensitivity in Chapter IV.  For Aim 3, we looked at the data pertaining to proprioception 
in Chapter V. Finally, for Aim 4, we looked at the data pertaining to strength in Chapter 
VI (Figure 3.1).   
 
Patient Cohort 
 
 Healthy Cohort 
Session 1: 
Pre-
injection 
Pain 
Sensitivity 
Proprioception Strength  
Pain  
Sensitivity 
Proprioception Strength 
Session 1:  
Pre-rest 
 
     ↓ ~15 min 
 
   
 
                  ~15 min ↓ 
 
Session 2: 
Post-
injection 
Pain 
Sensitivity 
Proprioception Strength  
Pain  
Sensitivity 
Proprioception Strength 
Session 2:  
Post-rest 
         
Figure 3.1. Study design for Aim 2, Aim 3, and Aim 4 
 
 
All data collection was completed on one day. Written and verbal instructions of 
testing procedures were provided, and written consent was obtained from each participant 
prior to testing. The experimental protocol was approved the Institutional Review Board 
at the University of Oregon.  
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Methods 
Patient Participants 
  
A total of twenty patients (ten males and ten females) presenting to Slocum 
Center for Orthopedics and Sports Medicine for unilateral subacromial pain syndrome 
(SPS) were included in the present study (Table 3.2 and Table 3.3). Prior to recruitment, 
patients met with a single treating orthopedist and were diagnosed with stage II 
impingement, also known as subacromial pain syndrome. Moreover, each patient 
participant had elected to receive a subacromial anesthetic injection as part of their 
standard of care treatment prior to the recruitment process. Subacromial injections for 
patient participants were administered by the same physician, MS, utilizing a 23 gauge 
needle and an anterolateral approach. The subacromial injection consisted of both an 
anesthetic (6 cc 0.5% Marcaine with Epinephrine) and corticosteroid agent (1 cc 
DepoMedrol). Following the injection, patient participants were given a 15 minute 
adjustment period during which time they were asked to move their arm to help disperse 
the agents within the subacromial bursa. 
To be diagnosed with stage II impingement, patients must have demonstrated a 
positive sign to the treating physician on at least three of the following five manual tests 
prior to receiving the injection: Hawkins-Kennedy, Neer, painful arc, empty can (Jobe), 
and painful external rotation resistance. After receiving the injection, the manual tests 
were repeated. In order to be diagnosed with stage II impingement, a patient had to 
demonstrate a positive injection sign, meaning their pain was significantly reduced during 
the manual tests in the post-injection testing relative to the pre-injection testing.  
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Exclusion criteria for patients included: a positive Spurling test, shoulder 
dislocation within the past three months, reproduction of shoulder pain with active or 
passive cervical range or motion, signs of a rotator cuff tear on manual tests (drop-arm 
test, lag signs, gross external rotation weakness) or imaging (fMRI or ultrasound were 
only available for some patients). Every patient had recent images (radiography or fMRI) 
to confirm the absence of moderate or severe glenohumeral arthritis. The healthy 
contralateral limb was also screened with manual tests to rule out bilateral impingement. 
Additional inclusion and exclusion criteria, as determined from the attending 
orthopedist’s physical exam and the patient’s self-reported history questionnaire, are 
provided in Table 3.1. 
  
Control Participants 
  
A total of twenty uninjured control participants (ten males and ten females) were 
recruited from the surrounding community via posted flyers and general advertisements. 
Each control participant was matched to a specific patient participant for age (±five 
years), sex, arm dominance and leg dominance (Table 3.2). Inclusion and exclusion 
criteria for control participants are provided in Table 3.1. 
  
  
 Self-Reported Measures 
  
Health History & Demographics - Information regarding age, sex, arm 
dominance, leg dominance and health history were obtained from each participant. Arm 
and leg dominance were determined by asking participants to indicate which limb (left, 
right) they would use to hold a pen and kick a ball, respectively. Anthropometric 
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measurements (height, weight, limb length, limb circumference) were taken by research 
personnel. 
 
 
Table 3.1. Inclusion and exclusion criteria for patients with subacromial pain syndrome 
and controls.  
 
Inclusion Criteria  
 Patients Controls 
Age 18-65 y/o   
Diagnosed with unilateral subacromial impingement, in absence 
of a suspected rotator cuff tear 
  
Pain present for longer than one month   
Received a subacromial injection with a positive injection sign   
Exclusion Criteria 
 Patients Controls 
Cervical range of motion restrictions or injury   
Cervical pain or pathology    
At the bilateral shoulders:  
- Moderate or severe glenohumeral osteoarthritis 
- Humeral head fractures 
- Glenohumeral arthroplasty 
- Rotator cuff tears or repairs 
- Joint laxity 
- Pain at rest (non-involved shoulder for patients; 
bilateral shoulders for controls) 
  
At the bilateral knees:  
- Tibiofemoral osteoarthritis 
- Total knee replacement 
- ACL tears or reconstruction 
- Pain at rest 
  
Neurological or chronic pain disorders   
Pregnancy   
 
 
 
Disability of the Arm, Shoulder and Hand (DASH) Questionnaire - The 
DASH questionnaire was administered to patients and controls prior to the injection/rest 
period. The DASH is a self-assessment questionnaire made up of 30 questions to measure 
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physical function and symptoms affecting the upper extremities. The questionnaire is 
scored from 0-100, with higher scores indicating greater disability (Hudak et al., 1996). 
The DASH has been shown to provide valid outcome measures (Gummesson et al., 2003) 
and is frequently employed in studies assessing patients with SPS (Camargo et al., 2015, 
2009; Ribeiro et al., 2016). 
 
Instrumented Measures 
 
 
Measurement of Pain Intensity - Pain intensity was measured by utilizing a 
series of visual analog scales (VAS) scales that asked the participants to indicate the 
highest pain intensity they experienced during a series of three maximum isomeric 
voluntary contractions (MVICs). The results were scored from 0-10 centimeters (0 cm = 
no pain, 10 cm = worst pain imaginable) in increments of one millimeter. Participants 
completed the VAS for the involved shoulder (IS), contralateral shoulder (CS), ipsilateral 
knee (IK) and contralateral (CK) at two time points: pre-injection and post-injection. 
Maximum isometric voluntary contractions at the shoulder joint were performed against 
resisted flexion, with participants in a seated position with the shoulder at ninety degrees 
of flexion. Maximum voluntary isometric contractions at the knee joint were performed 
against resisted extension, with participants in a seated position with the hip and knee 
joints flexed to ninety degrees. All MVICs were five seconds in duration with an interval 
of 30 second rest period between trials. Participants were blinded to their previous scores. 
 
Pain Sensitivity - Pain sensitivity was tested at both upper extremities and both 
lower extremities utilizing a pain pressure threshold (PPT) protocol.  Further details 
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about the PPT protocol can be found in Chapter IV, as pain sensitivity data was used to 
address Aim 2. 
 
Proprioception - Proprioception at both shoulders and both knees was assessed 
utilizing a joint position sense (JPS) protocol.  Further details about the JPS protocol can 
be found in Chapter V, as proprioception data was used to address Aim 3. 
 
Strength - Strength at both shoulders and both knees was assessed using a 
maximum voluntary isometric contraction (MVIC) protocol.   Further details about the 
MVIC protocol can be found in Chapter VI, as strength data was used to address Aim 4. 
 
 
Statistical Analysis  
 
 
Pain Reduction - To determine whether patients with SPS experienced a 
significant reduction in shoulder pain after the injection, dependent t-tests were run on 
patient data only.  The independent variable was time: pre-injection and post-injection.  
The dependent variable was VAS score at the involved shoulder.  
 
Patient vs. Control Demographics - To assess whether differences in 
demographics, anthropometrics, DASH, and VAS scores were present between patients 
with SPS and controls, a series of independent t-tests were run.  
 
Male Patient vs. Female Patient Demographics - To assess whether differences 
in demographics, anthropometrics, DASH, and VAS scores were present between female 
and male patients with SPS, a series of independent t-tests were run. To determine 
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whether patients experienced a significant reduction in shoulder pain after the injection, 
dependent t-tests were run comparing pre-injection VAS scores to post-injection VAS 
scores across the involved shoulder. 
 
Results 
An important requirement for this study was the successful reduction of shoulder 
pain in patients with SPS following a subacromial injection. Thus while twenty-one 
patients with SPS were recruited into the study, one patient was removed from the 
analysis owing to a lack of pain reduction as reported on post-injection versus pre-
injection VAS scores. The data presented are from the remaining twenty patients with 
SPS and the twenty controls that were matched to each patient. SPSS version 22 (IBM, 
Chicago, IL) was used for all statistical analysis. Values of p < 0.05 were regarded as 
statistically significant for all analysis. 
 
Pain Reduction  
The subacromial injection resulted in a marked reduction in pain for patients with 
SPS (p<0.001) resulting in a mean 54% reduction in pain scores (Table 3.3). 
 
Patient vs. Control Characteristics 
 
No significant differences were found between patient and control participants 
with respect to age, BMI, height or weight (all p>0.05). Significant differences were 
found between the two groups with respect to DASH scores, pre-injection VAS scores 
across the involved shoulder, and post-injection VAS scores across the involved shoulder 
(all p<0.001) (Table 3.2).  
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Table 3.2. Characteristics (means ± SDs) of patients with subacromial pain syndrome 
and controls.  
 Patients Controls 
   
   
Sex (males/females) 10 / 10 10 / 10 
   
Age (years) 51 ± 10 52 ± 10 
Height (cm) 169 ± 10 171 ± 10 
Weight (kg) 86 ± 18 80 ± 17 
BMI 30 ± 5 27 ± 4 
   
Dominant Arm (Right/Left) 16 / 4 16 / 4 
Dominant Leg (Right/Left) 16 / 4 16 / 4 
Injured Shoulder 
(Dominant/Non-dominant) 
6 / 14 ---    
     
DASH 38.6 ±16.8 2.6 ±3.6* 
Pre-injection VAS (0-10) 6.5 ± 2.6 0.0 ±0.1* 
Post-injection VAS (0-10) 2.9 ± 1.4 0.0 ±0.1* 
   
* Denotes a significant difference between patients with SPS and controls. 
 
 
 
 
Male Patient vs. Female Patient Characteristics 
 
No significant differences were found between male and female patients with 
respect to age, BMI, DASH scores, pre-injection VAS scores across the involved 
shoulder, and post-injection VAS scores across the involved shoulder (all p>0.05). 
Significant differences were found between the two groups with respect to height and 
weight (both p<0.001) (Table 3.3). 
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Table 3.3. Characteristics (means ± SDs) of male and female patients with subacromial 
pain syndrome. 
 
Males Females 
 
    
    
Number  10 10  
    
Age (years) 52 ± 8 51 ± 11  
Height (cm) 176 ± 10 163 ± 7+  
Weight (kg) 97 ± 16 76 ± 15+  
BMI 31 ± 5 29 ± 4  
    
Dominant Arm (Right/Left) 9 / 1 7 / 3  
Dominant Leg (Right/Left) 9 / 1 7 / 3  
Injured Shoulder  
(Dominant/Non-dominant) 
2 / 8 4 / 6  
    
DASH 36.8 ± 22.9 40.3 ± 7.5  
Pre-injection VAS (0-10) 7.0 ± 2.2 6.0 ± 2.9  
Post-injection VAS (0-10) 3.4 ± 1.6 2.6 ± 0.8  
    
+ Denotes a significant difference between male and female patients with SPS. 
 
 
Bridge 
In this chapter we described the participants and general methods utilized for Aim 
2 (Chapter IV), Aim 3 (Chapter V), and Aim 4 (Chapter VI) and ran statistical analyses 
on various demographic, disability, and pain variables. We found that patients with SPS 
had similar demographics to controls. This finding helped establish the validity of using 
data from control participants enrolled in this study as a baseline to compare the 
sensorimotor abilities of patients with SPS in the next chapter as well as upcoming 
chapters. We also found that male patients with SPS were similar in demographics as 
well as disability and pain scores to female patients with SPS.  This finding helped 
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establish the validity of comparing the sensorimotor abilities of male and female patients 
in the next chapter as well as upcoming chapters.  Finally, we found that patients with 
SPS experienced a significant reduction in pain following the subacromial injection. This 
finding helped establish the validity of using the injection intervention as an acute-pain 
reduction model and comparing the pre-injection sensorimotor abilities of patients with 
SPS to their post-injection values in the next chapter as well as upcoming chapters.  In 
the next chapter, Chapter IV, we specifically looked at the sensorimotor modality of pain 
sensitivity, and its associations with sex and pain. 
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CHAPTER IV 
 
PAIN HYPERSENSITIVITY IN SUBACROMIAL PAIN SYNDROME 
 
 The experiment described in this chapter was developed with Dr. Andrew 
Karduna who contributed substantially to this work by assisting with experimental 
conception, editing and advising throughout the project. Dr. Matthew Shapiro further 
contributed to the study by assisting in recruiting patients with subacromial pain and 
performing the subacromial injection. I was the primary contributor to the development 
of the experimental design, data collection and analysis, and write up. 
 
Introduction 
Following peripheral injury and inflammation, the nervous system utilizes a 
process called sensitization to change the response characteristics of neurons and protect 
the body from further damage. Sensitization is characterized by amplified neural 
responses to peripherally applied stimuli, ultimately resulting in pain hypersensitivity. 
Mechanisms responsible for this phenomena include, but are not limited to, reduced 
membrane thresholds, altered gene expressions and expanded receptor fields (Costigan et 
al., 2009; Koltzenburg et al., 1994; Woolf, 1983). 
In the early stages of injury and inflammation, sensitization is thought to largely 
be confined to primary afferent neurons within the injured area, a phenomenon referred to 
as peripheral sensitization (PS). Peripheral sensitization serves an essential role for 
healing, because it triggers salient warning sensations that lead to avoidance behaviors 
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and protect the injured area from further harm. However, in the presence of prolonged or 
intense pain, sensitization can transition from a helpful response to a harmful one. 
Specifically, prolonged or intense pain can initiate sensitization processes in nociceptive 
pathways across multiple levels of the central nervous system (CNS) in locations remote 
from the site of injury, a phenomenon termed central sensitization (CS). Since CS 
involves changes to neurons in the CNS, perceived pain intensity may be decoupled from 
the degree of tissue pathology (Costigan et al., 2009). Central sensitization has been 
observed in many chronic pain conditions (Bajaj et al., 2001; Herren-Gerber et al., 2004; 
Lluch et al., 2014; Petersen-Felix and Curatolo, 2002; Svendsen et al., 2004; Svensson et 
al., 2001), and is receiving increasing attention as a potential mechanism for the 
development and maintenance of chronic pain. 
Invasive procedures limit the direct measurement of sensitization in human 
patients, however quantitative sensory testing (QST) has allowed researchers and 
clinicians to obtain indirect measurements (Curatolo et al., 2006). Quantitative sensory 
testing can be assessed with several different modalities, with the most common 
involving the application of a temporary stimulus to the periphery and assessing the 
resulting pain response. Hypersensitive pain responses include sensations of pain at 
stimulus intensities that do not generally evoke pain in healthy participants or more 
intense pain sensations at standardized stimulus intensities. Using these methods, PS is 
detected whenever pain hypersensitivity is observed after the sensory stimulation of the 
injured area. Since peripheral mechanisms cannot account for hypersensitivity at healthy 
tissues that are remote to the site of injury, CS is detected whenever pain hypersensitivity 
is observed after stimulation of healthy areas. 
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Quantitative sensory testing has demonstrated that when compared to controls, 
patients with subacromial pain syndrome (SPS) are hypersensitive to a variety of 
experimentally applied stimuli, including heat, cold, prick and pressure (Alburquerque-
Sendín et al., 2013; Coronado et al., 2014; Gwilym et al., 2011; Hidalgo-Lozano et al., 
2010; Kindler et al., 2011; Paul et al., 2012). Specifically, hypersensitivity has 
consistently been observed across the symptomatic shoulder (Alburquerque-Sendín et al., 
2013; Gwilym et al., 2011; Hidalgo-Lozano et al., 2010; Paul et al., 2012), providing 
compelling evidence for the presence of PS. Remote locations, including the 
asymptomatic shoulder (Alburquerque-Sendín et al., 2013; Paul et al., 2012; Ribeiro et 
al., 2016) and lower extremities (Alburquerque-Sendín et al., 2013; Hidalgo-Lozano et 
al., 2010; Paul et al., 2012; Ribeiro et al., 2016) have shown inconsistent hypersensitivity, 
suggesting that CS may be present in subsets of the population (Sanchis et al., 2015). In 
light of this, additional information is needed about the relationship between CS and 
subacromial pain, as well as the individual characteristics associated with the 
development of CS, as the SPS population is likely to demonstrate heterogeneity. Female 
populations with pathologies of the rotator cuff suffer from higher levels of disability and 
pain compared to male populations, both prior to and after receiving treatment (Razmjou 
et al., 2011). It is possible that CS is more prevalent in female patients with SPS, 
contributing to the sex related differences in disability and pain. To our knowledge, no 
previous studies have assessed whether the development of CS is dependent upon sex in a 
population with SPS. This knowledge gap is surprising given the fact that females are 
known to more susceptible to the development of CS than males in other chronic pain 
conditions (Jensen and Petersen, 2006). 
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The presence of CS may hold particular promise for developing novel 
interventions aimed at treating SPS. Specifically, the presence of CS suggests that rather 
than solely being a product of peripheral tissue damage, the pain associated with SPS 
may have a central contribution. If patients with SPS display similar characteristics to 
animal models exhibiting CS (Latremoliere and Woolf, 2009), only a small degree of 
noxious input (mild tissue injury) is needed to maintain the sensitized state of neurons. 
It is currently unknown whether PS or CS persist after the reduction of 
subacromial pain. To our knowledge, only one investigation has assessed hypersensitivity 
in patients with SPS pre and post-treatment (Camargo et al., 2015). In that study, after a 
physical therapy regime, patients with SPS demonstrated reduced hypersensitivity (a 
higher pain tolerance) at the involved shoulder and contralateral shoulder, but not the 
lower extremity post-treatment. Given the lack of a healthy control group, these results 
are difficult to interpret. Another study has used pre-treatment data on CS to predict post-
treatment functional outcomes (Gwilym et al., 2011), however CS itself was not assessed 
post-treatment. In that study, patients who presented with greater levels of CS prior to 
treatment reported greater pain intensity post-treatment. This finding is not surprising 
given that several studies have shown a patient’s current pain intensity is highly 
correlated to CS level (Hidalgo-Lozano et al., 2010; Kindler et al., 2011). Central 
sensitization may not necessarily be a static condition, as long as peripheral pain is 
removed. A modulation of CS is associated with the acute removal of pain in other 
chronic conditions (Herren-Gerber et al., 2004), suggesting that CS is dynamic and 
responsive to the influence of peripheral nociceptors. However if CS persists in a 
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population of patients with SPS after pain reduction, clinical interventions may need to 
look beyond treatment for the local shoulder and also focus on central pain management. 
The primary aim of the present study was to assess PS and CS by testing 
pain hypersensitivity at involved and remote locations in patients with SPS, both 
before and after acute pain reduction. The secondary aim of the present study was 
to explore characteristics associated with the presence of CS. We hypothesized that 
patients with SPS would demonstrate a greater sensitivity to pain at the 
symptomatic shoulder and remote locations (contralateral shoulder, both knees) 
than matched controls (Hypothesis 2.1). We further hypothesized that upon pain 
reduction, patients experiencing SPS would demonstrate decreased sensitivity to 
pain at both shoulders and both knees relative to pre-injection values (Hypothesis 
2.2). Finally, we hypothesized that after controlling for pain duration and pain 
intensity, female patients would demonstrate greater sensitivity than male patients 
(Hypothesis 2.3). 
 
 
Methods 
 
General Methods and Participants 
 
 For Aim 2, Aim 3, and Aim 4, a single repeated measures study incorporating 
both a patient cohort with SPS and control cohort was utilized.  The methods and 
participants for this large study have previously been described in Chapter III. In the 
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present Chapter (IV), to specifically address Aim 2, pain sensitivity measurements from 
this larger dataset were evaluated and are expanded upon below.  
 
Pain Sensitivity 
 
Pain sensitivity was tested at both upper extremities and both lower extremities 
utilizing a pressure pain threshold (PPT) protocol. Measures of PPT, defined as the 
minimum force applied which induces pain, were obtained by utilizing a hand-held 
pressure algometer with a one-cm2 probe (Wagner Instruments). With participants in a 
seated position, upper extremity assessment sites were marked at the bilateral deltoid 
muscles, at the midpoint between the flat portion of the acromion and deltoid insertion 
(Figure 4.1). With participants in standing position, lower extremity assessment sites 
were marked at the bilateral vastus lateralis muscle, approximately five inches superior 
from the lateral edge of the patella (Figure 4.1). The researcher positioned the probe 
perpendicular to the assessment site and applied progressive pressure at a rate of 
approximately one kg/s. The participant was instructed to inform the assessor when they 
first perceived a sensation of pain or discomfort, at which point pressure application 
ceased and the PPT value was noted. Four measurements were obtained for each location 
with a 30 second interval between measurements. The order of testing (location and side) 
was blocked and randomized between participants. 
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Figure 4.1. Experimental set-up used for pressure pain threshold (PPT) measurements 
during the subacromial pain study. A) Deltoid location. B) Vastus lateralis location.  
 
 
 
Data Analysis 
 
Pre-injection PPT scores were calculated for each joint by taking the mean of the 
four assessments. Larger values indicate greater pressure was required to induce pain 
sensation. To assess the influence of the subacromial injection, the change in PPT scores 
was calculated for each joint by subtracting mean pre-injection PPT scores from mean 
post-injection PPT scores. A positive value indicates greater pressure was required to 
induce pain sensation during the post-injection condition relative to the pre-injection 
condition. 
 For the secondary analysis exploring the influence of sex, we created 
standardized z-scores for each of the four joints: involved shoulder, contralateral 
A B 
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shoulder, ipsilateral knee, and contralateral knee. Standardized z-scores were computed 
for each female patient using the equation below:  
4.1 
 Standarized Female Z − Score: 
X i.F − X̅ Controls.F
σX̅.F 
 
X̅Controls.F  is the mean PPT for the female control participants, σX̅.F  is the standard 
deviation of PPT scores for the female control participants, and X̅ i.F is the PPT score for 
an individual female patient participant. Likewise, standardized z-scores were computed 
for each male patient using the equation below:  
4.2 
 Standarized Male Z − Score: 
X i.M − X̅  Controls.M
σX̅.M 
 
X̅Controls.M is the mean PPT for the male control participants, σX̅.M  is the standard 
deviation of PPT scores for the male control participants, and X̅ i.M is the PPT score for an 
individual male patient participant.  
 
 
Statistical Analysis  
 
SPSS version 22 (IBM, Chicago, IL) was used for all statistical analysis. Values 
of p < 0.05 were regarded as statistically significant for all analysis. Following 
conventional ANOVA logic, interaction effects were evaluated before proceeding to 
main effects. 
 
Hypothesis 2.1– Patients with SPS would demonstrate a greater sensitivity to 
pain at the symptomatic shoulder and remote locations (contralateral shoulder, both 
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knees) than matched controls. To determine if there were differences in sensitivity 
between patient and control participants prior to treatment, a single two-way mixed 
model ANOVA was used. The dependent variable was PPT score. The between-subject 
effect was group and the within-subject effect was joint. Group had two levels: (a) patient 
and (b) control. Joint had four levels: (a) involved shoulder (IS), (b) contralateral 
shoulder (CS), (c) ipsilateral knee (IK), and (d) contralateral knee (CK). An a priori 
interaction contrast was also run for PPT scores to assess whether the differences 
between PPT scores for patient and control participants were different between the 
involved shoulder and remote joints. The a priori interaction contrast was coded as a 
group {1, -1} by joint {3, -1, -1, -1} interaction. To provide additional confirmation on 
the presence of hypersensitivity at the involved shoulder, an a priori paired t-test was run 
comparing patient’s involved shoulder to patient’s non-involved shoulder. 
 
Hypothesis 2.2 – Upon pain reduction, patients experiencing SPS would 
demonstrate decreased sensitivity to pain at both shoulders and both knees relative 
to pre-injection values. To determine if a pain reducing treatment influenced sensitivity 
a single two-way mixed model ANOVA was used. The dependent variable was change in 
PPT scores after treatment. The between-subject effect was group and the within-subject 
effect was joint. Group had two levels: (a) patient and (b) control. Joint had four levels: 
(a) involved shoulder (IS), (b) contralateral shoulder (CS), (c) ipsilateral knee (IK), and 
(d) contralateral knee (CK). An a priori interaction contrast was also run for change in 
PPT scores to assess whether the differences between PPT scores for patient and control 
participants were different between the involved shoulder and remote joints. The a priori 
interaction contrast was coded as a group {1, -1} by joint {3, -1, -1, -1} interaction. 
58 
 
Hypothesis 2.3 – After controlling for pain duration and pain intensity, 
female patients would demonstrate greater sensitivity than male patients. For this 
secondary analysis, we ran a total of four hierarchical multiple regression models, one for 
each joint (involved shoulder, non-involved shoulder, ipsilateral knee, contralateral knee) 
on patient data only. Standardized z-scores for PPT values were the dependent variable. 
Pain duration, pain intensity and sex were the independent variables. Sex was represented 
by dummy coded variables (0 = male, 1 = female). Pain duration and pain intensity were 
added to the model first, while sex was added to the model later to see if it increased the 
predictive power.  
 
Results 
 
Pre-injection Sensitivity: Hypothesis 2.1 
 
The a priori interaction comparison was significant (p<0.01), revealing that 
differences in patients and controls PPT scores were location dependent (involved joint 
versus remote joints). Based on this finding, pairwise comparisons were conducted. PPT 
scores at the involved shoulder were significantly smaller (p=0.02) in the patient (M=2.9 
kg) versus control population (M=4.1 kg), with a mean difference of 1.2 kg (Figure 4.2). 
Across all three remote joints, patient participants demonstrated smaller PPT scores than 
controls, with mean between group differences of 0.5 kg (Figure 4.2). However these 
between-group differences were not significant, neither when the remote joints were 
pooled into one composite score (p=0.38) nor when individual joints were analyzed 
including the contralateral shoulder (p=0.29), ipsilateral knee (p=0.43), and contralateral 
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knee (p=0.49). Additionally, the a priori paired t-test revealed that PPT scores were 
significantly smaller (p<0.01) at patients’ involved (M=2.9 kg) versus contralateral 
shoulder (M=3.4 kg), with a mean side-to-side difference of 0.5 kg (Figure 4.2). 
 
Post-injection vs. Pre-injection Sensitivity: Hypothesis 2.2 
 
For the change in PPT scores after treatment, the a priori interaction comparison 
was significant (p<0.05), revealing that differences between change scores in the patients 
and controls populations were location dependent (involved joint versus remote joints). 
Based on this finding, pairwise comparisons were conducted. Change scores at the 
involved shoulder were on average 0.3 kg greater in the patient population, however this 
between-group difference did not reach statistical significance (p=0.18) (Figure 4.3). 
Across the three remote joints, patient and control participants demonstrated similar 
change scores (mean between-group difference = 0.1 kg). Pairwise comparisons 
confirmed that between-group differences were not significant neither when the remote 
joints were pooled into one composite score (p=0.68) nor when individual remote joints 
were analyzed including the contralateral shoulder (p=0.22), ipsilateral knee (p=0.69), 
and contralateral knee (p=0.96). 
 
Within-Group Differences: Hypothesis 2.3 
For each of the four joints (involved shoulder, contralateral shoulder, ipsilateral 
knee, contralateral knee), the associated regression model incorporating only pain 
duration and pain intensity was non-significant (all p>0.05), however the addition of sex 
to the model significantly improved the prediction of standardized z-scores (all p<0.01). 
Therefore for each of the four joints, a simpler model incorporating only the main effects 
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of sex (Male = 0, Female = 1) was examined to determine how sex predicted z-scores 
(Table 4.1). For each joint, sex alone predicted over 44% of the variance in z-scores (R2 
range: 0.44 to 0.59, all p<0.01), and for all four joints, females patients’ z-scores were 
predicted to be significantly smaller than males (B range: -1.26 to -1.81, all p<0.01). 
Moreover, follow-up one sample t-tests revealed z-scores for males were not significantly 
different from zero at the involved shoulder (p=0.55), non-involved shoulder (p=0.59), 
ipsilateral knee (p=0.21), or contralateral knee (p=0.27) (Figure 4.4). Follow-up one 
sample t-tests revealed z-scores for females were significantly different from zero at the 
involved shoulder (p<0.001), non-involved shoulder (p<0.001), ipsilateral knee (p<0.01) 
and contralateral knee (p<0.01) (Figure 4.4).  
 
Discussion 
The aims of the present study were three-fold. First, we examined whether 
patients with SPS would exhibit characteristics of peripheral and central sensitization by 
looking at sensitivity across the involved shoulder as well as remote joints. Second, we 
assessed the effects of pain reduction (via an anesthetic injection) on sensitivity at the 
involved shoulder as well as remote joints. Lastly, we explored characteristics associated 
with the presence of PS and CS such as pain duration, pain intensity, and sex. Each of our 
hypotheses and corresponding results are discussed below.  
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Figure 4.2. Pre-injection pressure pain threshold (PPT) scores (means ± SEMs) for 
patients with SPS and controls. Analyzed joints include the involved shoulder (IS), 
contralateral shoulder (CS), ipsilateral knee (IK), contralateral knee (CK), and average of 
the CS, IK, and CK joints (Remote). * Denotes a significant between-group difference. + 
Denotes a significant within-group difference.  
 
 
 
Figure 4.3. Change in pressure pain threshold (PPT) scores (means ± SEMs) for patients 
with SPS and controls following the injection/rest period. Analyzed joints include the 
involved shoulder (IS), contralateral shoulder (CS), ipsilateral knee (IK), contralateral 
knee (CK), and average of the CS, IK, and CK joints (Remote). 
62 
 
Table 4.1. Regression results for standardized pain pressure threshold (PPT) z-scores for male and female patients. B is the 
unstandardized beta, and represents the slope of the line between the independent and dependent variables. SE B is the standard 
error for the unstandardized beta. 
 Involved  
Shoulder 
 Contralateral  
Shoulder 
 Ipsilateral  
Knee 
 Contralateral  
Knee 
 B SE B  B SE B  B SE B  B SE B 
1st Model            
Pain Duration (months) 0.00 0.01  0.00 0.01  0.00 0.01  0.01 0.01 
Pain Intensity (VAS 1-
10) 
0.00 0.11 
 
0.13 0.12 
 
0.11 0.08 
 
0.15 0.11 
 R2 0.01   0.06   0.11   0.15  
            
2nd Model            
Pain Duration (months) -0.01 0.01  -0.01 0.01  0.00 0.01  0.00 0.01 
Pain Intensity (VAS  
1-10) 
-0.08 0.07 
 
0.05 0.09 
 
0.06 0.07 
 
0.09 0.09 
Sex (0 = male; 1 = 
female) 
-2.02** 0.37 
 
-1.83* 0.49 
 
-1.22* 0.34 
 
-1.55* 0.71 
ΔR2 0.66**   0.44*   0.39*   0.33*  
            
3rd Model             
Constant -0.19 0.25  0.24 0.33  0.24 0.22  0.30 0.32 
Sex (0 = male; 1 = 
female) 
-1.81** 0.36 
 
-1.75* 0.46 
 
-1.26* 0.32 
 
-1.70* 0.45 
R2 0.59**   0.44*   0.47*   0.44*  
*Denotes significance at p < 0.01. ** Denotes significance at p < 0.00
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Figure 4.4. Pain pressure threshold (PPT) z-scores for male and female patients. A) 
Involved shoulder. B) Contralateral shoulder. C) Ipsilateral knee. D) Contralateral knee. 
Circles represent individual scores while diamonds represent group means. + Denotes a 
significant difference between male and female patients. * Denotes a significant 
difference from a one-sample test value of 0. 
 
 
Our first hypothesis that patients with SPS would demonstrate greater 
hypersensitivity than controls at the symptomatic shoulder as well as remote joints 
(contralateral shoulder, bilateral knees) was not supported. Our results found that patients 
had significantly lower PPT values at the involved shoulder only (Figure 4.1) in 
A B 
C D 
64 
 
comparison to controls, with the mean between-group differences being 1.22 kg. While 
lower PPT scores were observed at remote joints, these differences did not reach 
significance. Patients involved shoulder was also found to have significantly lower PPT 
values compared to the contralateral shoulder, with the mean side-to-side difference 
being 0.48 kg. 
Two previous studies have also found smaller PPTs on the order of 0.9-1.0 kg 
when the involved deltoid of patients was compared to controls. In contrast to the present 
study, these studies also demonstrated significantly smaller PPTs across the contralateral 
deltoid and lower extremities (Alburquerque-Sendín et al., 2013; Paul et al., 2012). 
Collectively, the present study paired with the findings of the previous studies suggest 
that persons with SPS have PS while only subsets of the population have CS. 
Consequently, it may be overly simplistic to classify SPS as having neuropathic 
tendencies. Instead, a greater emphasis on identifying the characteristics that put 
individuals most at risk for developing CS may be needed, including the influence of pain 
intensity, pain duration, and sex. Our results on the relationship between sex and 
sensitization are discussed later. 
Our second hypothesis that pain reduction (via an anesthetic injection) would 
result in decreased sensitivity across the involved shoulder and remote joints of patients 
with SPS relative to pre-injection data was not supported. No changes to sensitivity were 
observed following the injection (Figure 4.3). To our knowledge, only one previous study 
has assessed the influence of a pain reducing treatment on PPT scores in a population 
with SPS. In contrast to the present study, Camargo et al. found that both the 
symptomatic and contralateral shoulders demonstrated greater PPTs in the post-treatment 
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session compared to the pre-treatment session (2015), providing evidence that both PS 
and CS were reversed after the reduction of pain. The discrepancies between the present 
study and Camargo et al. may arise from differences in the length of time pain was 
reduced in patients as well as the mode of intervention. The present study assessed 
patients only 15 minutes after pain reduction induced via an anesthetic injection while 
Camargo et al. studied patients after four weeks of physical therapy intervention. 
Our third hypothesis that after controlling for pain duration and pain intensity, 
female patients would demonstrate greater sensitivity than males was supported. Our 
results revealed significantly greater z-scores in female compared to male patients at both 
the involved and remote joints, suggesting that the development of PS and CS in the SPS 
population may be sex specific. Moreover, when z-scores were compared to a sample test 
value of 0, neither the involved shoulder nor any of the remote joints of males were 
differently different than 0, while all joints of female patients were significantly smaller 
than 0. This suggests that female patients with SPS may be more predisposed to the 
development sensitization, which could be a contributing factor to the higher incidence of 
subacromial pain and poor outcomes in females. Interestingly, pain intensity and pain 
duration did not demonstrate a significant correlation with z-scores, suggesting that 
greater sensitization was not present in those with greater pain intensity or prolonged 
pain. 
There are several limitations to the present study. The first limitation concerns the 
fact that only one quantitative sensory test (PPT) was utilized in this study as a proxy to 
assess the presence of peripheral and central sensitization. It is possible that other 
quantitative sensory tests such as heat or cold tolerance would yield different conclusions 
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about the association between subacromial pain and sensitization. Also, there may be a 
difference between the acute and prolonged reduction of pain, therefore future studies are 
needed to look at the long-term effects of pain reduction on sensitization. 
 
Conclusions 
The present study found that as a whole, patients with SPS demonstrated 
hypersensitivity to pressure pain across the involved shoulder, providing evidence for PS, 
while remote joints demonstrated hypersensitivity that did not reach statistical 
significance. However, when patients with SPS were separated by sex, females 
demonstrated both PS and CS. Taken together, these findings suggest PS is associated 
with SPS while substantial heterogeneity likely exists with respect to CS, and one factor 
contributing to this heterogeneity may be sex. Moreover, pain reduction (through an 
anesthetic injection) had no influence on sensitivity in the short-term. Further studies are 
required to investigate which characteristics are associated with the development of PS 
versus CS as well as the influence of long-term pain reduction on peripheral and central 
sensitization. 
 
Bridge 
In the present chapter, patients with SPS were found to present heterogeneously in 
regards to the presence of PS and CS, with greater sensitization in females in the present 
study. This finding may help explain why females are reported to develop SPS 
disproportionally to males and have worse outcomes after treatment. No changes to 
sensitization were found after the injection intervention. While female with SPS had 
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greater sensitivity than their males, and treatment did not normalize sensitivity scores, it 
is still unclear how sex or treatment are related to other sensorimotor abilities. The next 
chapter, Chapter V, investigates the sensorimotor modality proprioception and the 
influence of sex and pain reduction on proprioceptive function. 
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CHAPTER V 
 
PROPRIOCEPTIVE ABNORMALITIES IN SUBACROMIAL PAIN SYNDROME 
 
The experiment described in this chapter was developed with Dr. Andrew 
Karduna who contributed substantially to this work by assisting with experimental 
conception, editing and advising throughout the project. Dr. Matthew Shapiro further 
contributed to the study by assisting in recruiting patients with subacromial pain and 
performing the subacromial injection. I was the primary contributor to the development 
of the experimental design, data collection and analysis, and write up. 
 
Introduction 
Proprioception is the ability to sense limb movement and position(Riemann and 
Lephart, 2002). Healthy proprioception is necessary to achieve optimal motor control and 
experimental or pathological disturbances to proprioception result in detrimental changes 
to coordinated agonist/antagonist activation as well as movement patterns (Ghez and 
Sainburg, 1995; Messier et al., 2003; Park et al., 1999). Poor proprioception has been 
documented at the symptomatic shoulder of patients with subacromial pain syndrome 
SPS (Anderson and Wee, 2011; Bandholm et al., 2006; Machner et al., 2003; Maenhout 
et al., 2012; Morl et al., 2011). Consequently, poor proprioception may be contributing to 
the abnormal motor patterns associated with SPS, which may in turn contribute to the 
development or progression of the disease. 
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Although an association between poor proprioception and SPS has been 
established with limited evidence (Fyhr et al., 2015), including evidence for a worse 
sense of joint position (Anderson and Wee, 2011; Morl et al., 2011), a higher threshold to 
detection of passive motion (Machner et al., 2003), and a decreased ability to produce 
steady force or estimate force (Bandholm et al., 2006; Maenhout et al., 2012), the 
mechanisms of this link are not well established. It has been suggested that changes to 
proprioception in SPS are the result of dysfunction to mechanoreceptors surrounding the 
symptomatic shoulder (Fyhr et al., 2015), as trauma and muscle atrophy could decrease 
the overall number of mechanoreceptors while pain could alter fusimotor activity 
(Thunberg et al., 2002). If mechanoreceptor dysfunction is indeed to blame, poor 
proprioception is a local effect of SPS and should be confined to the symptomatic 
shoulder. Alternatively, it is possible that poor proprioception in SPS arises from global 
mechanisms that are distinct from mechanoreceptor dysfunction. General mechanisms 
could include: i) interference in the transmission of afferent information within the spinal 
cord secondary to pain, ii) interference in the interpretation or integration of afferent 
information at supraspinal centers secondary to pain, or iii) global proprioceptive deficits 
that pre-existed the development of SPS and predisposed the patient to injury. 
The extent to which global mechanisms contribute to poor proprioception in 
patients with SPS can be evaluated by measuring proprioception across the symptomatic 
shoulder, asymptomatic shoulder and remote joints. If deficits are present at the 
asymptomatic shoulder and a remote joint, a general mechanism of poor proprioception 
would be implicated since local mechanoreceptor dysfunction would be insufficient to 
explain deficits extending beyond the symptomatic shoulder. Interestingly, a number of 
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studies looking at upper and lower extremity musculoskeletal injuries have shown 
proprioceptive deficits across both the involved and non-involved limb (V Baker et al., 
2002; Bank et al., 2013b; Koralewicz and Engh, 2000; Roberts et al., 2000), despite the 
presence of a unilateral injury. One study has even found that after reconstructive surgery 
for unilateral glenohumeral instability, proprioception across both shoulders significantly 
improved compared to baseline (Potzl et al., 2004), while another study has found that 
upper extremity proprioceptive impairments accompany knee osteoarthritis and lower 
extremity deficits in proprioception (Lund et al., 2008). These findings imply general 
mechanisms are contributing to proprioceptive deficits, in at least some unilateral 
musculoskeletal conditions. 
 Unfortunately few studies have compared the non-involved shoulder or remote 
joints of patients with SPS to healthy participants. Hence, it remains unconfirmed 
whether general mechanisms contribute to the proprioceptive deficits in this population. 
While a few studies have attempted to statistically compare the non-involved shoulder of 
patients with SPS to controls, these studies were underpowered (Anderson and Wee, 
2011; Haik et al., 2013). Furthermore, to our knowledge, only one study has assessed 
proprioception at a joint other than the shoulder in patients with SPS. Compared to 
healthy controls, a previous study in our lab found poorer joint position sense at the 
symptomatic shoulder and ipsilateral elbow of patients with SPS than uninjured controls 
(Ettinger et al., 2017). Due to the presence of bi-articular muscles crossing the shoulder 
and adjacent elbow joint as well as the shared innervation between these joints, we were 
unable to deduce whether local or generalized mechanisms contributed to the deficits at 
the elbow joint. In light of this, there is a need to clarify whether proprioceptive deficits 
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are a local or global presentation in SPS and whether pain helps or hinders 
proprioception. It would also be helpful to investigate the individual characteristics 
associated with the development of abnormal proprioception, as the SPS population may 
demonstrate heterogeneity. Female populations with pathologies of the rotator cuff suffer 
from higher levels of disability and pain compared to male populations both prior to and 
after receiving treatment (Razmjou et al., 2011). It is possible that proprioceptive deficits 
are more prevalent in female patients with SPS, contributing to the sex related differences 
in disability and pain. To our knowledge, no previous studies have assessed whether 
proprioceptive abnormalities are dependent upon sex in a population with SPS despite the 
fact that other sensory abnormalities, including hypersensitive pain processing is more 
enhanced in females than males with chronic pain (Jensen and Petersen, 2006). 
The primary aim of the present study was to assess regional and global 
abnormalities to proprioceptive function by testing joint position sense at involved 
and remote locations in patients with SPS, both before and after acute pain 
reduction. The secondary aim of the present study was to explore characteristics 
associated with the presence of abnormal proprioception. We hypothesized that 
patients experiencing SPS would demonstrate worse proprioception at the 
symptomatic shoulder as well as remote joints (contralateral shoulder, both knees) 
than matched controls (Hypothesis 3.1). We further hypothesized that upon pain 
reduction, patients experiencing SPS would demonstrate worse proprioception both 
shoulders and both knees relative to pre-injection values (Hypothesis 3.2). We also 
hypothesized that after controlling for pain duration and pain intensity, female 
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patients would demonstrate greater proprioceptive errors than male patients 
(Hypothesis 3.3). 
 
Methods 
General Methods and Participants 
 
 For Aim 2, Aim 3, and Aim 4, a single repeated measures study incorporating 
both a patient cohort with SPS and control cohort was utilized.  The methods and 
participants for this large study have previously been described in Chapter III. In the 
present Chapter (V), to specifically address Aim 3, proprioception measurements from 
this larger dataset were evaluated and are expanded upon below.  
 
Proprioception 
Proprioception at the involved shoulder (IS), contralateral (shoulder), ipsilateral 
knee (IK) and contralateral knee (CK) was assessed utilizing an active-active joint 
position sense (JPS) protocol. Measurements were obtained by affixing a 5th generation 
iPod Touch to participants. For the shoulder joints, the iPod was attached to the lateral 
aspect of the humerus, approximately two inches above the elbow joint via an elastic 
band (Figure 5.1). For the knee joints, the iPod was attached to the lateral aspect of 
shank, approximately two inches above the ankle via an elastic band (Figure 5.1).  
The iPod ran on a custom developed app that emitted auditory cues and calculated 
joint angles with respect to gravity utilizing data from the tri-axial accelerometer and tri-
axial gyroscope. The validity of the app has previously been validated in a field setting 
and compared to a similar protocol involving an electromagnetic tracking device(S. 
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Edwards et al., 2016). Each JPS trial consisted of an active positioning phase followed by 
an active repositioning phase. Following is an explanation of each phase of a JPS trial.  
1. Baseline position – At the beginning of the trial, the participant assumed a 
relaxed baseline position. 
2. Positioning phase – The positioning phase began with a low-pitched sound, 
prompting the participant to leave the baseline position. The pitch (or frequency) of the 
auditory tone provided the participant with feedback about the angle of their joint relative 
to the target. When the participant attained the target (defined as ± 3˚from the desired 
joint angle) the participant was directed to hold the target position and memorize its 
location. After holding the target for three seconds, the participant returned to the 
baseline position and held the baseline position for one second. 
3. Repositioning phase – Without auditory feedback from the app, the participant 
repositioned their joint away from baseline and into the previously memorized target. 
After maintaining a static position (defined as velocity less than 0.25 degrees/sec) for one 
second, the device recorded the participant’s position. 
During testing, participants were seated with their eyes closed. To minimize 
extraneous cues across the lower extremity, both male and female participants wore 
shorts and removed their shoes. Likewise, to minimize extraneous cues across the upper 
extremity, females wore sleeveless shirts or sports bras while males wore sleeveless shirts 
or no shirt. Prior to data collection, participants performed several practice trials at non-
test angles to become acquainted with the protocol. The number of practice trials varied 
by participant and was determined by the researcher based on the participant’s 
competency with the protocol. 
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Assessment of the shoulder joints involved shoulder flexion performed in the 
sagittal plane while seated in a backless chair. During all testing, the participant was 
instructed to keep the elbow locked in extension and the thumb pointed upwards. Four 
targets were presented in a random order at the shoulder, once each at: 75, 80, 85, and 90 
degrees. Assessment of the knee joints involved knee extension performed seated with 
the hip flexed to 90 degrees. During all testing, the participant was instructed to keep the 
ankle locked at 90 degrees. Four targets were presented at the knee, once each at: 40, 45, 
50, and 55 degrees. The testing of joints and sides was randomized and counterbalanced 
between participants. 
 
Data Analysis 
 After data collection, each trial was analyzed with custom written LabVIEW 
(National Instruments, Austin, TX) software. The difference between the repositioned 
angle and presented angle was termed repositioning error. If the repositioned angle 
involved greater excursion than the target angle this was called an overestimation and 
given a positive sign. 
 
Two dependent variables were calculated for the pre-injection JPS assessments at 
each of the four joints: 
1. Constant Error (CE) – this was defined as the mean repositioning error. Constant 
errors represent accuracy with directional bias and were calculated as proposed by 
Schmidt and Lee (Schmidt and Lee, 1999). A positive value for CE indicates 
greater joint excursion occurred during the repositioning phase relative to the 
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presented phase and a negative value indicates smaller joint excursion occurred 
during the repositioning phase relative to the presented phase.  
2. Variable Error (VE) – this was defined as the population standard deviation from 
the mean of constant errors. Variable errors represent the ability of participants to 
consistently sense test positions and were calculated as proposed by Schmidt and 
Lee (Schmidt and Lee, 1999). Larger values indicate larger variability in 
repositioning errors between trials.  
 
Two dependent variables were calculated for the influence of injection on JPS at 
each of the four joints: 
1. Change in Constant Error (ΔCE) – this was defined as the mean difference 
between the post-injection and pre-injection constant error scores. A positive sign 
indicates greater joint excursion occurred in the post-injection condition relative 
to the pre-injection condition. 
2. Change in Variable Error (ΔVE) – this was defined as the mean difference 
between the post-injection and pre-injection variable error scores. A positive sign 
indicates greater variability occurred in the post-condition condition relative to the 
pre-injection condition. 
 
For the secondary analysis exploring the influence of sex, we created standardized 
z-scores for each of the four joints: involved shoulder, contralateral shoulder, ipsilateral 
knee, and contralateral knee. Standardized z-scores were computed for each patient using 
the equation below:  
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5.1 
 Standarized Z − Score: 
X i − X̅  Controls
σ X̅
 
X̅ Controls is the mean CE or VE for the control participants, σ X̅ is the standard deviation 
of CE or VE scores for the control participants, and X i is the CE or VE score for an 
individual patient participant. 
 
Statistical Analysis 
SPSS version 22 (IBM, Chicago, IL) was used for all statistical analysis. Values 
of p < 0.05 were regarded as statistically significant for all analysis. Following 
conventional ANOVA logic, interaction effects were evaluated before proceeding to 
main effects. 
Hypothesis 3.1 – Patients experiencing SPS would demonstrate worse 
proprioception at the symptomatic shoulder as well as remote joints (contralateral 
shoulder, both knees) than matched controls. To determine if there were differences in 
JPS scores between patient and control participants prior to treatment, a total of two two-
way mixed-effects ANOVAs were used. The two dependent variables were constant error 
and variable error scores prior to treatment. For both ANOVAs, the between-subject 
effect was group and the within-subject effect was joint. Group had two levels: (a) patient 
and (b) control. Joint had four levels: (a) involved shoulder (IS), (b) contralateral 
shoulder (CS), (c) ipsilateral knee (IK), and (d) contralateral knee (CK). Two a priori 
interaction contrasts were also run for constant and variable errors to assess whether the 
differences between JPS scores for patient and control participants were different 
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between the involved shoulder and remote joints. The a priori interaction contrasts were 
coded as a group {1, -1} by joint {3, -1, -1, -1} interaction. 
 
 
       
 
        
 
Figure 5.1. Experimental set-up used for proprioception measurements during the 
subacromial pain study. A) Shoulder in rest position. B) Shoulder in reaching position. C) 
Knee in rest position. D) Knee in reaching position.  
A B 
C D 
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Hypothesis 3.2 – Upon pain reduction, patients experiencing SPS would 
demonstrate worse proprioception both shoulders and both knees relative to pre -
injection values. To determine if a pain reducing treatment influenced JPS a total of two 
two-way mixed model ANOVA were used. The two dependent variables were change in 
constant error and change in variable error scores after treatment. For both ANOVAs, the 
between-subject effect was group and the within-subject effect was joint. Group had two 
levels: (a) patient and (b) control. Joint had four levels: (a) involved shoulder (IS), (b) 
contralateral shoulder (CS), (c) ipsilateral knee (IK), and (d) contralateral knee (CK). 
Two a priori interaction contrasts were also run for change in constant and change in 
variable errors to assess whether the differences between JPS scores for patient and 
control participants were different between the involved shoulder and remote joints. The 
a priori interaction contrasts were coded as a group {1, -1} by joint {3, -1, -1, -1} 
interaction. 
 
Hypothesis 3.3 – After controlling for pain duration and pain intensity, 
female patients would demonstrate greater proprioceptive errors than male 
patients. For this secondary analysis, we ran a total of four hierarchical multiple 
regression models, one for each joint (involved shoulder, non-involved shoulder, 
ipsilateral knee, contralateral knee) on patient data only. Standardized z-scores were the 
dependent variable. Pain duration, pain intensity and sex were the independent variables. 
Sex was represented by dummy coded variables (Males = 0, Females = 1). Pain duration 
and pain intensity were added to the model first, while sex was added to the model later 
to see if it increased the predictive power. 
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Results 
Pre-injection Proprioception: Hypothesis 3.1 
For constant errors, the a priori interaction comparison was non-significant 
(p=0.35), revealing that differences between patient and control populations did not 
depend upon location (involved shoulder versus remote joints). We next looked at the 
ANOVA interaction, where the group*joint interaction (p=0.64) was also found to be 
non-significant. Finally, following conventional ANOVA logic, we looked at the main 
effects. The main effect of joint (p=0.70) was non-significant while the main effect of 
group was significant (p<0.05). Across all four joints, both patient and control 
participants demonstrated a repositioning bias in favor of an overshoot (Figure 5.2). This 
overshoot was significantly smaller in patients (M=2.0 degrees) versus controls (M=3.4 
degrees) however, as group was found to be a significant main effect (p<0.05). 
For variable errors, the a priori interaction comparison was non-significant 
(p=0.57). Following this finding, we looked at the ANOVA group*joint interaction 
which was also non-significant (p=0.24). The main effects of joint (p=0.76) and group 
(p=0.68) were also found to be non-significant for variable error (Figure 5.2). 
 
Post-injection vs. Pre-injection Proprioception: Hypothesis 3.2 
For the change in constant errors after treatment, the a priori interaction 
comparison was non-significant (p=0.75), revealing that differences between patient and 
control populations did not depend upon location (involved shoulder versus remote 
joints). We next looked at the ANOVA interaction, where the group*joint interaction 
(p=0.59) was also found to be non-significant. Finally, following conventional ANOVA 
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logic, we looked at the main effects. The main effect of joint (p=0.91) was non-
significant. Across all four joints, patient participants demonstrated greater overshoots of 
the target after the injection (M=0.7 degrees), while no changes were observed for 
controls (M=0.0 degrees) (Figure 5.3). This between-group difference did not reach 
significance however, as the main effect of group was non-significant (p=0.19). 
For the change in variable errors after treatment, the a priori interaction 
comparison was non-significant (p=0.79). Following this finding, we looked at the 
ANOVA group*joint interaction which was also non-significant (p=0.64). The main 
effects of joint (p=0.62) and group (p=0.80) were also found to be non-significant for 
change in variable error (Figure 5.3). 
 
Within-Group Differences: Hypothesis 3.3 
For both standardized constant error z-scores as well as standardized variable 
error scores at all four joints (involved shoulder, contralateral shoulder, ipsilateral knee, 
contralateral knee), the associated regression models incorporating only pain duration and 
pain intensity were all non-significant (all p>0.05). Moreover, the addition of sex to the 
models did not significantly improve the prediction of standardized z-scores (all p>0.05) 
(Table 5.1 and Table 5.2). None of the Beta coefficients associated with the predictors 
were significant (all p>0.05). 
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Figure 5.2. Pre-injection proprioception scores (means ± SEMs) for patients with SPS 
and controls. A) Constant error scores. B) Variable error scores. * Denotes a significant 
between-group difference. 
 
A 
B 
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Figure 5.3. Change in proprioception scores (means ± SEMs) for patients with SPS and 
controls following the injection/rest period. A) Constant error scores. B) Variable error 
scores.
A 
B 
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Table 5.1. Regression results for standardized constant error z-scores for male and female patients. B is the unstandardized 
beta, and represents the slope of the line between the independent and dependent variables. SE B is the standard error for the 
unstandardized beta. 
 
 Involved  
Shoulder 
 Contralateral  
Shoulder 
 Ipsilateral  
Knee 
 Contralateral  
Knee 
 B SE B  B SE B  B SE B  B SE B 
1st Model            
Pain Duration 
(months) 
0.03 0.01 
 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
Pain Intensity (VAS 
1-10) 
0.11 0.06 
 
0.12 0.05 
 
0.10 0.06 
 
-0.04 0.08 
 R2 0.17   0.28   0.11   0.01  
            
2nd Model            
Pain Duration 
(months) 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
Pain Intensity (VAS 
1-10) 
0.00 0.06 
 
0.11 0.05 
 
0.10 0.06 
 
-0.02 0.09 
Sex (0 = male;  
1 = female) 
-0.23 0.33 
 
-0.14 0.28 
 
-0.18 0.31 
 
0.43 0.45 
ΔR2 0.02   0.01   0.02   0.05  
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Table 5.2. Regression results for standardized variable error z-scores for male and female patients. B is the unstandardized 
beta, and represents the slope of the line between the independent and dependent variables. SE B is the standard error for the 
unstandardized beta.  
 
 Involved  
Shoulder 
 Contralateral  
Shoulder 
 Ipsilateral  
Knee 
 Contralateral  
Knee 
 B SE B   B SE B   B SE B   B SE B  
1st Model            
Pain Duration 
(months) 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
 
-0.01 0.01 
Pain Intensity (VAS 
1-10) 
-0.04 0.08 
 
-0.11 0.07 
 
-0.03 0.07 
 
-0.24 0.13 
 R2 0.01   0.13   0.02   0.21  
            
2nd Model            
Pain Duration 
(months) 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
 
-0.01 0.01 
Pain Intensity (VAS 
1-10) 
-0.02 0.09 
 
-0.12 0.08 
 
-0.05 0.07 
 
-0.26 0.14 
Sex (0 = male;  
1 = female) 
0.43 0.45 
 
-0.17 0.40 
 
-0.61 0.35 
 
-0.49 0.71 
ΔR2 0.05   0.01   0.16   0.02  
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Discussion 
The aims of the present study were three-fold. First, we examined whether 
proprioceptive impairments were present at a local (involved shoulder only) or global 
level (remote joints) in a population with SPS. Second, we assessed the effects of pain 
reduction (via an anesthetic injection) on proprioceptive measures at local and global 
levels in a population with SPS. Lastly, we explored characteristics associated with the 
presence of abnormal proprioception such as pain duration, pain intensity, and sex. Each 
of our hypotheses and corresponding results are discussed below.  
Our first hypothesis that patients with SPS would demonstrate worse 
proprioception at the symptomatic shoulder as well as remote joints (contralateral 
shoulder, bilateral knees) than matched controls was not supported. In contrast, our 
results showed that patients had significantly better repositioning accuracy (as measured 
by constant errors) across all four tested joints (Table 5.1) than controls. The superior 
accuracy of the patient group could not be explained by changes in the variability of 
repositioning, as the consistency of errors between the four trials (as measured by 
variable error) was not significantly different between patients and controls. 
Previous studies utilizing JPS protocols similar to ours have found a strong 
tendency for healthy populations to overshoot presented targets, with reported errors for 
shoulder flexion(Ettinger et al., 2017; King et al., 2013; S. Edwards et al., 2016) and knee 
extension (Vanessa Baker et al., 2002; Stillman et al., 1998) being on the order of 2°- 5° 
and 0.5°- 4°, respectively. An overshoot bias, similar to those reported above, was found 
at the bilateral shoulders and knees (Table 5.2) of patient and control participants enrolled 
in the present study. Across all joints, the overshoot bias was ~1.4° smaller in patients 
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compared to controls, resulting in better accuracy in the patient population. The tendency 
for patients with shoulder pain to undershoot the target relative to controls is in 
agreement with a previous JPS study by Anderson et al. (Anderson and Wee, 2011) 
conducted in the scapular plane. In the Anderson et al. study, patients with Chronic 
Rotator Cuff Pathology (which encompasses both SPS and glenohumeral instability) had 
a propensity to underestimate targets across not only the involved shoulder but the non-
involved shoulder as well, while controls tended to overestimate targets. In contrast to the 
present study, these relative undershoots resulted in worse proprioceptive acuity in the 
patient population. Using a force reproduction tasks, Maenhout et al.(2012) also found 
differences in the involved and non-involved shoulders of patients with SPS compared to 
controls. Specifically, patients overestimated the force target across both shoulders by 
~6% while controls underestimated the force target by ~6%. This resulted in no 
proprioceptive advantage for either group. Collectively, the present study paired with the 
findings of Anderson et al. and Maenhout et al. suggest that persons with SPS have 
altered proprioception across both shoulders; however these alterations may lead to 
improved, impaired or equivalent magnitudes of errors relative to controls depending 
upon the task. Consequently, it may be overly simplistic to quantify proprioceptive acuity 
based on the magnitude of errors alone, and classify alterations as a proprioceptive 
‘advantage’ or ‘deficit.’ Instead, a greater emphasis on investigating the specific sensory, 
motor, or integration mechanisms underlying the proprioceptive alterations in a 
population with SPS are required. 
Earlier studies have generally proposed that local sensory and motor factors, 
including differences in the number and sensitivity of mechanoreceptors or abnormal 
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recruitment of scapulothoracic muscles patterns play a role in the altered proprioceptive 
ability of patients with SPS. These concepts imply that proprioceptive alterations should 
be limited to the symptomatic shoulder and potentially the contralateral asymptomatic 
shoulder. However the fact that we found alterations across not only both shoulders but 
both knees argues against a local relationship. Our results indicate that patients with SPS 
have more global alterations in proprioception that cannot be entirely explained by 
mechanisms localized to the shoulder joints. To our knowledge, only one other study has 
assessed proprioception at a joint other than the shoulder in patients with SPS. Consistent 
with our results, a previous study in our lab (Ettinger et al., 2017) found proprioceptive 
alterations at the ipsilateral elbow during a joint positioning task. A possible explanation 
for the presence of proprioceptive alterations at remote joints is that these alterations 
preceded and precipitated the development of SPS. Although it was beyond the scope of 
the present cross-sectional study to investigate this theory, our results following the 
anesthetic injection suggest that pain may be a contributing factor and alterations are 
secondary to the development of SPS. 
Our second hypothesis that pain reduction (via an anesthetic injection) would 
result in worse proprioception at the symptomatic shoulder and remote joints relative to 
pre-injection values was partially supported. Following the injection, all tested joints 
demonstrated a trend for greater overshoots and diminished proprioceptive accuracy (as 
measured by constant errors) on the order of ~0.7° compared to pre-treatment (Table 5.2). 
Consequently, patient constant error scores became more similar to controls errors scores 
after the injection; however patients still demonstrated smaller errors. No changes in the 
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consistency of repositioning (as measured by variable errors) were found following the 
injection. 
To our knowledge, only one previous study has assessed the influence of an 
anesthetic injection on proprioception in a population with SPS. Similar to the present 
study, an earlier study performed by our lab (Ettinger et al., 2017) found that the 
symptomatic shoulder demonstrated greater overshoots and diminished proprioceptive 
accuracy on the order of ~1.8° in the post-injection session compared to the pre-injection 
session. Unlike the present study, these changes reached statistical significance. 
Moreover, patients were found to have significantly larger errors than controls in the 
post-injection session but not pre-injection session. The discrepancies between the 
present study and our earlier study (Ettinger et al., 2017) may arise from differences in 
pain reduction between the patient populations. The present study found a pain reduction 
of ~54% while the earlier study found a reduction of ~72% following treatment. If pain is 
indeed contributing to proprioceptive alterations, it seems logical that greater reductions 
in pain could account for the more robust changes demonstrated by the earlier study. 
In our earlier study (Ettinger et al., 2017), we suggested that a reduction in 
sensory information likely contributed to the increase in proprioceptive errors post-
injection. Specifically, patients with SPS may use pain, a very salient sensory signal, to 
help gauge the position of their arm and thus alleviation of pain reduces proprioceptive 
inputs. Against this argument however, is the fact that patients in the present study were 
found to have larger errors across remote joints as well as the involved shoulder after the 
injection, implicating more global factors. 
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Several factors could explain the global changes to proprioception that occurred 
between the pre-injection and post-injection sessions. First, the changes could be related 
to changes in cognitive attention. Joint positioning tasks demand a high degree of 
concentration (Lund et al., 2008) and lower levels of concentration may actually improve 
proprioception. Ghai et al.(Ghai et al., 2016) found smaller proprioceptive errors across 
the knee joint when participants performed a secondary cognitive task simultaneously 
versus no cognitive task. These findings agree with the Reinvestment Theory, which 
proposes that automatic movement patterns can be disrupted and impaired if the 
performer tries to exert to much conscious control over the movements (Masters and 
Maxwell, 2008). Pain is known to disrupt attentional performance in both healthy adults 
exposed to acute pain and patients with chronic pain (Eccleston and Crombez, 1999; 
Kucyi and Davis, 2015; Moore et al., 2012). This implies that patients in the present 
study likely had larger attentional disruptions prior to treatment when pain was high 
versus after the pain reducing injection, thus providing a proprioceptive advantage for the 
pre-injection session.  
Another explanation for the global changes to proprioception after treatment 
could be related to a central pain inhibition across the motor system. Numerous studies 
have shown that muscles adapt to pain by reducing movement velocity, range of motion, 
muscle forces, and agonist activity (Graven-Nielsen et al., 2002, 1997; Lund et al., 1991). 
The Pain Adaption Model explains such behaviors as a protective adaption aimed at 
protecting the body from further harm (Lund et al., 1991). While the Pain Adaptation 
Model has primarily been investigated in relation to alterations at the symptomatic joint, 
increasing evidence suggests that pain can induce motor alterations at the contralateral or 
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remote joints. If patients had reduced movement velocities or greater agonist inhibition in 
the pre-injection condition, pain inhibition could explain the relative underestimation of 
targets in the pre-injection versus post-injection condition. The pre-injection bias is also 
likely to reduce torques across the joint, which again points at a protective mechanism 
that limits muscle strains. 
Our third hypothesis that after controlling for pain duration and pain intensity, 
female patients would demonstrate greater proprioceptive errors than male patients was 
not supported. Our results did not reveal significant z-score differences between male and 
female patients, suggesting that the proprioceptive abnormalities noted in the SPS 
population were not sex specific. Therefore our results do not support the notion that sex 
specific differences in proprioceptive impairments contribute to the higher rates of 
subacromial pain and failed treatment noted in female versus male patients. Interestingly, 
pain intensity and pain duration did not demonstrate a significant correlation with z-
scores, suggesting that greater proprioception abnormalities were not present in those 
with greater pain intensity or prolonged pain. 
There are several limitations to the present study. The first limitation concerns the 
fact that only one of the sub-modalities of proprioception (joint position sense) was 
evaluated in this study. It is possible that other modalities such as kinesthesia and force 
steadiness would yield different conclusions about the influence of pain on global 
proprioceptive abilities. While a repeated model design for both our control and patient 
participants accounted for any learning bias or fatigue, we cannot conclusively establish a 
causal role for pain reduction and proprioceptive changes. It is possible that the changes 
observed between testing sessions were the result of the mechanical effects or anxiety of 
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the injection. The use of a placebo treatment condition for our patients or exposure to an 
anesthetic injection for controls could have helped account for this. Also, there may be a 
difference between the acute and prolonged reduction of pain, therefore future studies are 
needed to look at the long-term effects of pain reduction on proprioception. 
 
Conclusions 
The present study found that patients with SPS demonstrate altered proprioception 
across not only the involved shoulder but remote joints as well, including the 
contralateral shoulder and bilateral knees. Specifically, patients with SPS when compared 
to controls were found to utilize a repositioning bias with smaller overshoots across each 
of the tested joints. Moreover, pain reduction (through an anesthetic injection) resulted in 
larger repositioning errors as compared to pre-treatment values, across all tested joints. 
Female patients did not exhibit greater proprioceptive abnormalities than male patients. 
Taken together, these findings suggest proprioception is altered at a global rather than 
local level in persons with SPS and that pain may play a role in initiating a central 
protective mechanism. Further studies are required to investigate whether sensory, motor 
or integration centers are responsible for the differences in JPS noted between patients 
and controls as well as the influence of long-term pain reduction. 
 
 
Bridge 
In the present chapter, we found that proprioception was abnormal at both the 
involved and remote joints of persons with subacromial pain syndrome, but these 
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abnormalities did not appear to be sex dependent. Moreover, the reduction of pain 
coincided with changes in proprioceptive function that were more similar to the 
proprioceptive function of uninjured controls than the pre-injection testing session.  Since 
proprioception is an important component for motor control, it is possible that motor 
abnormalities may also present at the involved and remote joints, and may be influenced 
by the reduction of pain. The next chapter, Chapter VI investigated strength, a motor 
modality, and the influence of sex and pain reduction on weakness across the involved 
shoulder and remote joints.  
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CHAPTER VI 
 
WEAKNESS IN SUBACROMIAL PAIN SYNDROME 
 
The experiment described in this chapter was developed with Dr. Andrew 
Karduna who contributed substantially to this work by assisting with experimental 
conception, editing and advising throughout the project. Dr. Matthew Shapiro further 
contributed to the study by assisting in recruiting patients with subacromial pain and 
performing the subacromial injection. I was the primary contributor to the development 
of the experimental design, data collection and analysis, and write up. 
 
Introduction 
Weakness frequently accompanies chronic and acute pain (Bank et al., 2013a; 
Graven-Nielsen et al., 2002; Lund et al., 1991). While multiple hypotheses have emerged 
regarding the precise neurophysiological pathways contributing to this weakness (Hodges 
and Tucker, 2011; Lund et al., 1991), it is generally accepted that weakness is induced to 
protect damaged muscles from further injury. To elaborate, pain appears to override 
motor commands, inhibiting motor unit recruitment and force generation in an effort to 
protect the injured structures from further damage (Tucker et al., 2009). In the case of 
subacromial pain syndrome (SPS), significant weakness in abduction and external 
rotation has been consistently demonstrated at the symptomatic shoulder (Leroux et al., 
1994; MacDermid et al., 2004; McCabe et al., 2005; Tyler et al., 2005). This weakness is 
interpreted as inhibition of the supraspinatus and infraspinatus, as the supraspinatus is 
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accepted to contribute to abduction and external rotation while the infraspinatus external 
rotation (Escamilla et al., 2009; Webb et al., 2014). An inhibition of the supraspinatus 
and infraspinatus is consistent with current pain models, as the nociceptive stimulus 
associated with SPS is accepted to arise from near or even within these muscles (Ben-
Yishay et al., 1994; Park et al., 2008; Soifer et al., 1996), and thus inhibition of these 
muscles could be interpreted as a protective mechanism. While rotator cuff weakness 
may offer protection to these muscles in the acute phases of subacromial pain, the 
prolonged weakness associated with SPS may lead to further disease progression. 
In healthy individuals, the humeral head remains relatively fixed on the glenoid 
during reaching tasks (Deutsch et al., 1996; Yamaguchi et al., 2000), allowing the greater 
tuberosity of the humerus to freely pass underneath the acromion. In contrast, the 
humeral head has been observed to migrate superiorly on the glenoid in much of the SPS 
population (Deutsch et al., 1996), especially at higher elevation angles. Since the 
subacromial space is relatively small, even a subtle narrowing of acromiohumeral 
distance is a potential mechanisms for substantial compression of soft tissue structures 
and subsequent pain for at least a subset of patients (Karduna et al., 2005). 
One factor that likely contributes to a narrowing of acromiohumeral distance in 
the SPS population is weakness or an insufficient contribution from the rotator cuff. Due 
to the mobility of the glenohumeral joint and its limited bony congruence, the dynamic 
action of the rotator cuff muscles plays a crucial role in providing stability to the joint 
(Apreleva et al., 2000). Among other actions, the rotator cuff muscles preserve the size of 
the subacromial space by limiting superior translation of the humeral head (Yanagawa et 
al., 2008), especially during elevation tasks. When lifting the arm, the deltoid muscle 
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serves as the prime mover of the glenohumeral joint. However, contraction of the deltoid 
muscle also produces shear forces which serve to superiorly displace the humeral head 
(Yanagawa et al., 2008). To offset the superior displacement invoked by the deltoid, 
compressive and inferior shear forces are generated by contraction of the rotator cuff 
muscles (Halder et al., 2001). Subsequently, a proper balance of rotator cuff and deltoid 
forces results in limited movement of the humeral head. In contrast, weakness of the 
rotator cuff muscles results in an increase in superior translation of the humeral head 
(Chen et al., 1999; Keener et al., 2009; San Juan et al., 2013) and a narrowing of the 
subacromial space. 
Patients with SPS have been shown to have a high incidence of both rotator cuff 
weakness as well as a reduction in subacromial space (Burkhart, 1995; Deutsch et al., 
1996). While these observations do not define whether a cause and effect relationship 
exists between rotator cuff weakness and superior translations of the humeral head, this 
relationship can be examined with experimental models. Experimental fatigue (Chen et 
al., 1999) and suprascapular nerve blocks (San Juan et al., 2013) have been shown to 
result in superior translations of the humeral head that were not present prior to the 
experimentally induced rotator cuff weakness. On the other hand, there is ample evidence 
that some patients with SPS possessed congenital narrowing of the subacromial space 
prior to developing rotator cuff weakness or pain, due to bony anatomy (Balke et al., 
2014, 2013). Nonetheless, regardless of whether narrowing of the subacromial space 
preceded or ensued from the onset of SPS and rotator cuff weakness, the prevention of 
further subacromial space narrowing is thought to be crucial to prevent disease 
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progression. Consequently, to maintain subacromial space, it may be necessary for 
patients to regain rotator cuff strength. 
Due to consistent observations of rotator cuff weakness in SPS and the potential 
effects of this weakness on the size of the subacromial space, it is important to understand 
the mechanisms underlying rotator cuff weakness. Like other pain conditions, nociceptive 
pathways may be playing a role in the weakness observed in SPS. Healthy participants 
exposed to experimental subacromial pain demonstrate a substantial loss of strength 
relative to  their strength pre-pain induction (Stackhouse et al., 2013). Patients with large 
rotator cuff tears, a condition which is thought to be a continuum of SPS,  demonstrate 
large increases in shoulder strength minutes after experiencing pain reduction from a 
subacromial injection (Itoi et al., 1997; Kirschenbaum et al., 1993). Given these findings, 
the weakness observed in patients with SPS may be directly modulated by pain. In light 
of this, additional information is needed about the relationship between weakness and 
subacromial pain as well as the individual characteristics associated with the 
development of weakness as the SPS population is likely to demonstrate heterogeneity. 
Female populations with pathologies of the rotator cuff suffer from higher levels of 
disability and pain compared to male populations both prior to and after receiving 
treatment (Razmjou et al., 2011). It is possible that shoulder weakness is more prevalent 
in female patients with SPS, contributing to the sex related differences in disability and 
pain. To our knowledge, no previous studies have assessed whether the development of 
weakness is dependent upon sex in a population with SPS. This knowledge gap is 
surprising given the poorer outcomes noted in female patients. 
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When assessing strength deficits, clinicians and research alike often compare the 
symptomatic side of patients experiencing subacromial pain to the non-symptomatic side 
(McCabe et al., 2005; Tyler et al., 2005). This technique assumes that pain does not 
modulate strength at the healthy side, which may be an erroneous assumption. While a 
number of investigations have obtained strength measurements from the asymptomatic 
shoulder of persons with SPS (Camargo et al., 2008; Leroux et al., 1994; MacDermid et 
al., 2004; Mattiello-Rosa et al., 2008; Tyler et al., 2005), few of these investigations have 
statistically compared the non-involved shoulder of patients to healthy controls (Camargo 
et al., 2008; Leroux et al., 1994; Mattiello-Rosa et al., 2008). Of the studies that have 
made this comparison, two have found strength deficits at the non-involved shoulder 
(Camargo et al., 2008; Mattiello-Rosa et al., 2008) and one has found no deficits (Leroux 
et al., 1994). Additional studies are needed to confirm whether rotator cuff weakness 
presents bilaterally in patients with SPS. Furthermore, given the cross-sectional nature of 
these previous studies, it cannot be determined whether pain was related to the deficits at 
the non-involved limb. However, acute pain has been shown to cause bilateral changes in 
motor unit recruitment (Schomburg et al., 2015)and cortical activation (Xiao et al., 2015) 
in animal models. If pain is leading to bilateral weakness in the SPS population, it would 
be inappropriate to use the non-involved limb as a control. In addition to the motor 
disturbances noted at the non-involved arm including altered kinematic patterns (Hebert 
et al., 2002) and longer times to perform occupational tasks or produce peak torque 
(Camargo et al., 2008; Madeleine et al., 1999), persons with SPS also display larger COP 
displacement while performing occupational tasks (Madeleine et al., 1999), suggesting 
that motor control abnormalities may extend beyond the bilateral shoulders.  
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The primary aim of this study was to assess regional and global weakness by 
testing peak isometric torque at involved and remote locations in patients with SPS, 
both before and after acute pain reduction. The secondary aim of the present study 
was to explore characteristics associated with weakness. We hypothesized that 
patients with SPS would demonstrate smaller peak torque values at the 
symptomatic shoulder and remote locations (contralateral shoulder, both knees) 
than matched controls (Hypothesis 4.1). We further hypothesized that upon pain 
reduction, patients experiencing SPS would demonstrate greater peak torque values 
at both shoulders and both knees relative to pre-injection values (Hypothesis 4.2). 
We also hypothesized that after controlling for pain duration and pain intensity, 
female patients would demonstrate smaller normalized peak torque than male 
patients (Hypothesis 4.3). 
 
 
Methods 
General Methods and Participants 
 
 For Aim 2, Aim 3, and Aim 4, a single repeated measures study incorporating 
both a patient cohort with SPS and control cohort was utilized.  The methods and 
participants for this large study have previously been described in Chapter III. In the 
present Chapter (VI), to specifically address Aim 4, strength measurements from this 
larger dataset were evaluated and are expanded upon below.  
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Strength 
Strength at the involved shoulder (IS), contralateral (shoulder), ipsilateral knee 
(IK) and contralateral knee (CK) was assessed utilizing a maximum isomeric voluntary 
contractions MVIC protocol to calculate peak torque. Measurements were obtained from 
a computerized system consisting of a uniaxial load cell, amplifier, and data acquisition 
unit running on custom written LabVIEW (National Instruments, Austin, TX) software. 
Graphical representation of contraction force was visible on a monitor in real time to 
research personnel but not participants. Data were sampled at 1000 Hz and recorded as 
force. For each joint, the peak (or maximum) force produced out of the series of three 
trials was used for data analysis.   
The testing procedure was strictly standardized, including participant positioning, 
contraction time, rest time between trials, number of trials per side, and verbal instruction 
and encouragement. The MVICs at the shoulder joint were performed against resisted 
sagittal plane flexion of the upper extremity, with the shoulder in 90 degrees of flexion, 
the elbow in full extension and the forearm in neutral pronation/supination. Participants 
were in a seated position and the trunk was stabilized with straps (Figure 6.1). The load 
cell was mounted to a metal testing frame and positioned just distal to the medial and 
lateral epicondyles of the humerus. The MVICs at the knee joint were performed against 
resisted sagittal plane extension, with the hip and knee joints flexed to ninety degrees and 
ankle joint in a neutral position (Figure 6.1). Participants were in a seated position and 
the trunk and thighs were stabilized with straps (Figure 6.1). The load cell was mounted 
to a metal testing frame and positioned four inches proximal to the medial and lateral 
malleoli of the ankle. 
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Each joint was tested three times, with thirty seconds of rest in between each trial. 
The testing of sides was randomized and counterbalanced between participants. 
Participants were verbally encouraged by the investigator during each muscle contraction 
and instructed to continue the contraction for five seconds. Feedback about performance 
was not given to participants.  
 
 
 
        
Figure 6.1. Experimental set-up used for peak torque (strength) measurements during the 
subacromial pain study. A) Shoulder flexion. B) Knee extension.  
 
 
Data Analysis 
For each joint, the pre-injection peak force score (N) was converted to a peak 
torque score (Nm). To calculate peak torque, peak force was multiplied by the moment 
arm (defined as the distance between the center of the shoulder joint and the center of the 
load cell). The moment arm was measured with a seamstress ruler from the center of the 
joint (shoulder or knee) to the middle of the point of contact with the load cell. Larger 
A B 
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peak torque values indicate greater strength was exerted against the load cell. To assess 
the influence of the subacromial injection, the change in peak torque scores was 
calculated for each joint by subtracting peak pre-injection torque scores from peak post-
injection torque scores. A positive value indicates greater torque (strength) was applied 
during the post-injection condition relative to the pre-injection condition. 
For the secondary analysis exploring the influence of sex, we created standardized 
z-scores for each of the four joints: involved shoulder, contralateral shoulder, ipsilateral 
knee, and contralateral knee. Standardized z-scores were computed for each female 
patient using the equation below:  
6.1 
 Standarized Female Z − Score: 
X i.F − X̅ Controls.F
σX̅.F 
 
X̅Controls.F  is the mean peak torque for the female control participants, σX̅.F  is the 
standard deviation of peak torque scores for the female control participants, and X̅ i.F is 
the Peak Torque score for an individual female patient participant. Likewise, 
standardized z-scores were computed for each male patient using the equation below.  
 
6.2 
 Standarized Male Z − Score: 
X i.M − X̅  Controls.M
σX̅.M 
 
X̅Controls.M is the mean peak torque for the male control participants, σX̅.M  is the standard 
deviation of peak torque scores for the male control participants, and X̅  i.M is the peak 
torque score for an individual male patient participant.  
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Statistical Analysis  
SPSS version 22 (IBM, Chicago, IL) was used for all statistical analysis. Values 
of p < 0.05 were regarded as statistically significant for all analysis. Following 
conventional ANOVA logic, interaction effects were evaluated before proceeding to 
main effects. 
 
Hypothesis 4.1– Patients with SPS would demonstrate smaller peak torque 
values at the symptomatic shoulder and remote locations (contralateral shoulder, 
both knees) than matched controls. To determine if there were strength differences 
between patient and control participants prior to treatment, a single two-way mixed 
model ANOVA was used. The dependent variable was peak torque. The between-subject 
effect was group and the within-subject effect was joint. Group had two levels: (a) patient 
and (b) control. Joint had four levels: (a) involved shoulder (IS), (b) contralateral 
shoulder (CS), (c) ipsilateral knee (IK), and (d) contralateral knee (CK). An a priori 
interaction contrast was also run for peak torque scores to assess whether the differences 
between torque scores for patient and control participants were different between the 
involved shoulder and remote joints. The a priori interaction contrast was coded as a 
group {1, -1} by joint {3, -1, -1, -1} interaction. To provide additional confirmation on 
the presence of weakness at the involved shoulder, an a priori paired t-test was run 
comparing patient’s involved shoulder to patient’s non-involved shoulder. 
 
Hypothesis 4.2 – Upon pain reduction, patients experiencing SPS would 
demonstrate greater peak torque values at both shoulders and both knees relative to 
pre-injection values. To determine if a pain reducing treatment influenced strength a 
103 
 
single two-way mixed model ANOVA was used. The dependent variable was change in 
peak torque after treatment. The between-subject effect was group and the within-subject 
effect was joint. Group had two levels: (a) patient and (b) control. Joint had four levels: 
(a) involved shoulder (IS), (b) contralateral shoulder (CS), (c) ipsilateral knee (IK), and 
(d) contralateral knee (CK). An a priori interaction contrast was also run for change in 
peak torque to assess whether the differences between torque for patient and control 
participants were different between the involved shoulder and remote joints. The a priori 
interaction contrast was coded as a group {1, -1} by joint {3, -1, -1, -1} interaction. 
 
Hypothesis 4.3 – After controlling for pain duration and pain intensity, 
female patients would demonstrate smaller normalized peak torque than male 
patients. For this secondary analysis, we ran a total of four hierarchical multiple 
regression models, one for each joint (involved shoulder, non-involved shoulder, 
ipsilateral knee, contralateral knee) on patient data only. Standardized z-scores for torque 
were the dependent variable. Pain duration, pain intensity and sex were the independent 
variables. Sex was represented by dummy coded variables. Pain duration and pain 
intensity were added to the model first, while sex was added to the model later to see if it 
increased the predictive power. 
 
Results 
Pre-injection Peak Torque: Hypothesis 4.1 
The a priori interaction comparison was significant (p<0.01), revealing that 
differences between patients and controls peak torques were location dependent (involved 
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joint versus remote joints). Based on this finding, pairwise comparisons were conducted. 
Peak torques at the involved shoulder were significantly smaller (p=0.04) in the patient 
population (M= 34.9 Nm) versus the control population (M=48.5 Nm), by a mean of 13.6 
Nm (Figure 6.2). There were no significant differences between groups at the remote 
joints, neither when the remote joints were pooled into one composite score (p=0.92) nor 
when individual joints were analyzed including the contralateral shoulder (p=0.68), 
ipsilateral knee (p=0.75), and contralateral knee (p=0.79). Additionally, the a priori 
paired t-test revealed that peak torques were significantly smaller (p<0.001) at patients’ 
involved (M=34.9 Nm) versus contralateral (M=48.7 Nm) shoulder, with a mean side-to-
side difference of 13.8 Nm (Figure 6.2). 
 
Post-injection vs. Pre-injection Peak Torque: Hypothesis 4.2 
For the change in peak torque after treatment, the a priori interaction comparison 
was non-significant (p=0.46), revealing that differences between patient and control 
populations did not depend upon location (involved shoulder versus remote joints). We 
next looked at the ANOVA interaction, where the group*joint interaction (p=0.69) was 
also found to be non-significant. Finally, following conventional ANOVA logic, we 
looked at the main effects. Neither was the main effect of joint (p=0.76) nor group 
(p=0.76) significant (Figure 6.3). 
 
Within-Group Differences: Hypothesis 4.3 
For the involved shoulder, the associated regression model incorporating only 
pain duration and pain intensity was non-significant (p=0.31), however the addition of 
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sex to the model significantly improved the prediction of standardized z-scores (p=0.03). 
Therefore a simpler model incorporating only the main effects of sex (Male = 0, Female 
= 1) was examined to determine how sex predicted z-scores at the involved shoulder 
(Table 6.1). Sex alone predicted 27% of the variance in z-scores (p=0.02), and females 
patients z-scores were predicted to be significantly smaller than males (B= -1.49, 
p=0.02). Moreover, a follow-up one sample t-test revealed z-scores for males were not 
significantly different from zero at the involved shoulder (z-score=-0.69, p=0.10) while 
z-scores for females were significantly smaller than zero (z-score=-2.18, p<0.001) 
(Figure 6.4). 
For each of the three remote joints (contralateral shoulder, ipsilateral knee, 
contralateral knee), the associated regression models incorporating only pain duration and 
pain intensity were non-significant (all p>0.05). Neither did the addition of sex to the 
models significantly improve the prediction of standardized z-scores (all p>0.05). To 
increase power, simpler models incorporating only the main effects of sex were examined 
to determine how sex predicted z-scores at each remote joint (Table 6.1). The simpler 
models were also found to be non-significant (all p>0.05) (Table 6.1). 
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Figure 6.2. Pre-injection peak torque (strength) scores (means ± SEMs) for patients with 
SPS and controls. Analyzed joints include the involved shoulder (IS), contralateral 
shoulder (CS), ipsilateral knee (IK), contralateral knee (CK), and average of the CS, IK, 
and CK joints (Remote). * Denotes a significant between-group difference. + Denotes a 
significant within-group difference.  
 
 
 
 
 
Figure 6.3. Change in peak torque (strength) scores (means ± SEMs) for patients with 
SPS and controls following the injection/rest period. Analyzed joints include the involved 
shoulder (IS), contralateral shoulder (CS), ipsilateral knee (IK), contralateral knee (CK), 
and average of the CS, IK, and CK joints (Remote). 
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Figure 6.4. Peak torque z-scores for male and female patients at the involved shoulder. 
Circles represent individual scores while diamonds represent group averages. + Denotes a 
significant difference between male and female patients. * Denotes a significant 
difference from a one-sample test value of 0. 
 
 
 
 
Discussion 
The aims of the present study were three-fold. First, we examined whether 
patients with SPS would smaller peak torque values than controls across the involved 
shoulder as well as remote joints. Second, we assessed the effects of pain reduction (via 
an anesthetic injection) on peak torque at involved shoulder as well as remote joints. 
Lastly, we explored characteristics associated with weakness such as pain duration, pain 
intensity, and sex. Each of our hypotheses and corresponding results are discussed below. 
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Table 6.1. Regression results for standardized peak torque (strength) z-scores for male and female patients. B is the 
unstandardized beta, and represents the slope of the line between the independent and dependent variables. SE B is the standard 
error for the unstandardized beta.  
 Involved  
Shoulder 
 Contralateral  
Shoulder 
 Ipsilateral  
Knee 
 Contralateral  
Knee 
 B SE B  B SE B  B SE B  B SE B 
1st Model            
Pain Duration 
(months) 
0.01 0.01 
 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
Pain Intensity (VAS 
0-10) 
-0.06 0.13 
 
0.14 0.14 
 
-0.08 0.08 
 
-0.06 0.08 
 R2 0.13   0.05   0.15   0.13  
            
2nd Model            
Pain Duration 
(months) 
0.01 0.01 
 
0.00 0.01 
 
0.00 0.01 
 
0.00 0.01 
Pain Intensity (VAS 
0-10) 
-0.12 0.12 
 
0.09 0.14 
 
-0.11 0.08 
 
-0.10 0.07 
Sex (0 = male; 1 = 
female) 
-1.45* 0.61 
 
-1.22 0.76 
 
-0.77 0.39 
 
-0.77 0.38 
ΔR2 0.23*   0.15   0.16   0.18  
            
3rd Model             
Constant -0.69 0.41  0.61 0.46  0.18 0.27  0.13 0.26 
Sex (0 = male; 1 = 
female) 
-1.49* 0.58 
 
-1.22 0.65 
 
-0.75 0.39 
 
-0.75 0.36 
R2 0.27*   0.16   0.17   0.19  
* Denotes significance at p < 0.05
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Our first hypothesis that patients with SPS would demonstrate smaller peak 
torque compared to controls at the symptomatic shoulder as well as remote joints 
(contralateral shoulder, bilateral knees) was partially supported. Our results found that 
patients had significantly smaller peak torque values at the involved shoulder only 
(Figure 6.1). Controls produced 48.5 Nm of torque at the involved shoulder while 
patients produced 34.9 Nm, resulting in between-group differences of 13.6 Nm or 28% 
less torque in the patient group. This finding suggests patients with SPS in the present 
study had substantial weakness. Similarly, patients involved shoulder was also found to 
have significantly lower peak torques compared to the contralateral shoulder, with the 
mean side-to-side difference being 13.8 Nm or 28% less torque at the involved shoulder. 
 Previous strength testing of populations with SPS have utilized a variety of test 
positions including external rotation, internal rotation, abduction, and elevation motions 
among others, as well as a variety of protocols, including isometric and isokinetic, 
making it difficult to directly compared the results of the present study to previous studies 
in terms of magnitudes of weakness. Nonetheless our results are consistent with a large 
body of literature demonstrating weakness at the involved shoulder of patients with SPS 
in a variety of positions and during a variety of protocols (Camargo et al., 2008; Leroux 
et al., 1994; MacDermid et al., 2004; McCabe et al., 2005; Tyler et al., 2005; Warner et 
al., 1990). Moreover, our results also suggest that the weakness patient with SPS 
experience is significant as a value of 15% is commonly accepted as clinically relevant. 
Limited studies have found emerging evidence for motor abnormalities across the 
noninvolved shoulder of persons with SPS including changes in time to peak torque or 
acceleration (Camargo et al., 2010; Mattiello-Rosa et al., 2008). Moreover, while a large 
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number of studies assess strength across the non-involved shoulder, few have statistically 
compared this shoulder to a control population. To our knowledge, only one study has 
found peak torque deficits in the non-involved shoulder (Camargo et al., 2008). The 
present study found no evidence for weakness at the non-involved shoulder. Collectively, 
these findings make it difficult to determine whether strength deficits are present 
bilaterally in a population with SPS. Nonetheless, given that patients with SPS are likely 
to utilize their non-involved arm more than they did prior to injury, it is likely that some 
motor adaptations have occurred. 
Our second hypothesis that pain reduction (via an anesthetic injection) would 
result in increased strength across the involved shoulder and remote joints of patients 
with SPS was not supported. No changes to peak torque were observed across any joints 
following the injection (Figure 6.3). In the long-term, patients with SPS have been shown 
to experience strength gains across the involved shoulder after a variety of interventions 
that successfully reduced their pain (McClure et al., 2004; Viswanath et al., 2013; Yu et 
al., 2006), however it is unclear whether strength gains are possible after the acute 
reduction in pain. Similar to the present study, Park et al. failed to find isometric strength 
gains across the involved shoulder in a population of 153 patients with SPS thirty minutes 
after a subacromial injection (Park et al., 2008). Interestingly, Park et al. also tested a 
population with rotator cuff tears, finding that strength gains did occur (Park et al., 2008). 
A number of other studies have shown acute strength gains after a pain relieving injection 
in populations with rotator cuff tears or mixed rotator cuff tear and SPS populations(Ben-
Yishay et al., 1994; Itoi et al., 1997; Kirschenbaum et al., 1993). Collectively our results 
paired with previous studies suggest that patients with SPS may not have the same motor 
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responses to acute pain removal as patients with rotator cuff tears, despite the fact that 
SPS and rotator cuff tears are viewed as a continuum of diseases. Unlike patients with 
rotator cuff tears, in order for patients with SPS to regain strength, additional time or 
interventions may be needed in addition to a subacromial injection. The lack of changes 
to strength could also be due to the position that we used. A flexion task such as the one 
we used required contributions from both the supraspinatus and deltoid. However it is 
possible that a different motion that required more torque generation to come from the 
impaired rotator cuff muscles, such as external rotation, could show greater inhibition and 
changes. 
Our third hypothesis that after controlling for pain duration and pain intensity, 
female patients would demonstrate greater weakness than male patients was supported. 
Our results revealed significantly greater z-scores at the involved shoulder in female 
compared to male patients, indicating that female patients experienced greater weakness 
than male patients. Interestingly, pain intensity and pain duration did not demonstrated a 
significant correlation with z-scores, suggesting that greater strength deficits were not 
present in those with greater pain intensity pain or prolonged pain. To our knowledge, no 
previous studies have evaluated whether sex differences contribute differentially to motor 
responses in SPS. Similar to our study however, Higgins et al. found that females with 
rotator cuff tears exhibited greater normalized strength deficits than males(Earle Miller et 
al., 2016). The association between weakness and the female sex may hold promise 
future research on shoulder pain as female patients generally report greater physical 
limitations than male patients both before and after treatment. 
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There are several limitations to the present study. The first limitation concerns the 
fact that only one position was utilized in this study to assess strength. It is possible that 
other positions such as external rotation would yield different conclusions about the 
influence of pain on rotator cuff strength. Also, there may be a difference between the 
acute and prolonged reduction of pain, therefore future studies are needed to look at the 
long-term effects of pain reduction on strength.  
 
Conclusions 
The present study found that patients with SPS demonstrate weakness, as 
measured by smaller peak torques, across the involved shoulder while remote joints 
appear to demonstrate normal strength. Female patients were shown to exhibit greater 
levels of weakness than male patients at the involved shoulder. Moreover, pain reduction 
(through an anesthetic injection) had no influence on strength in the short-term. Further 
studies are required to investigate which characteristics are associated with the 
development of weakness as well as the influence of sex on motor responses to treatment. 
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CHAPTER VII 
 
CONCLUSIONS 
 
Patients with subacromial pain syndrome (SPS) display a number of sensorimotor 
deficits including alterations in pain processing, poor proprioception, and weakness at the 
symptomatic limb. The primary purpose of this dissertation was to explore whether the 
aforementioned deficits: (1) can be quantified by using the non-involved limb as a 
measure of control, (2) are purely localized to the symptomatic limb or represent a more 
generalized deficit, (3) are influenced by the presence of subacromial pain, and (4) 
present similarly in male and female patients. Here, we utilized modern clinical 
techniques in both a patient cohort with SPS and uninjured control cohort to address these 
aims. The results of this dissertation are applicable towards treatment of SPS as well as 
scientific understanding of sex on sensorimotor behavior. 
Clinicians and researchers frequently determine whether an individual patients or 
patient population have alterations in sensorimotor function by utilizing the contralateral 
limb as a control.  Our results have shown that asymmetries exist between the dominant 
and non-dominant shoulders in regards to pressure pain threshold, proprioception, and 
strength.  Moreover, the asymmetries associated with each of these sensorimotor 
modalities were each found to be sex dependent.  The implications of our results raise 
concerns about the utility of using the contralateral limb as a control, and instead give 
weight to the use of a control group that is tightly matched for sex and arm dominance, 
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especially in research settings.  In the long-term, it may be advantageous to develop a 
correction factor for clinical use.   
This dissertation also found that sensorimotor abnormalities may not be limited to 
the involved shoulder of persons with subacromial pain syndrome.  Specifically, we 
found evidence for heightened sensitivity to pressure pain threshold and improved 
proprioception across remote limbs as well as the involved limb, while weakness 
appeared to be localized to the involved shoulder.  These results suggest that, at least in 
some subsets of the population, subacromial pain syndrome may have some neuropathic 
involvement.  Consequently, some patients may require interventions that extend beyond 
treating the local shoulder joint.  
Much to our surprise, no statistically significant changes occurred after the 
reduction of pain in any of our measured sensorimotor modalities.  The absence of 
significant sensorimotor changes after acute pain reduction makes it difficult to determine 
the extent to pain is contributing to the sensorimotor abnormalities found in this study. 
Nonetheless, we feel the use of an anesthetic injection model that acutely reduces pain, 
may be an advantageous for other chronic pain conditions affecting the joints, such as 
knee osteoarthritis.  
In two of our three sensorimotor measures, abnormalities were sex dependent, 
with females demonstrating greater abnormalities than males.  This finding should be 
explored further as this may help explain why females have higher incidents of 
subacromial pain and failed treatment.  
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